{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import glob"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_df(path, encoding=\"utf-8\"):\n",
    "    loaded_pd = pd.read_csv(path, sep=\"\\t\", encoding=encoding)\n",
    "    pd_name = path.split(\"/\")[-1].split(\".\")[0]\n",
    "    return pd_name, loaded_pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "paths_expression = glob.glob(\"data/expression data/*.txt\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "expression_data = []\n",
    "for path in paths_expression:\n",
    "    expression_data.append(load_df(path))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "paths_other = glob.glob(\"data/*.txt\")\n",
    "aligner_path = \"data/phenotypes_id_aligner.txt\"\n",
    "other_data = []\n",
    "for path in paths_other:\n",
    "    if path == aligner_path:\n",
    "        other_data.append(load_df(path, encoding=\"latin\"))\n",
    "    else:\n",
    "        other_data.append(load_df(path))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## We have loaded the dataframes to lists\n",
    "\n",
    "Each list contains tuples (name, dataframe)\n",
    "- expression_data: tables with gene expressions\n",
    "- other_data: all the remaining tables"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "Immune = other_data[3][1][other_data[3][1]['Category'] == 'Immune']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Infectious disease, immune system: H5N1 influenza A virus mortality rate 30 days after infection (10^4 EID-50 of HK213 virus in 30 microliters saline) [% death]',\n",
       " 'Infectious disease, immune system: H5N1 influenza A virus survival time (10^4 EID-50 of HK213 virus in 30 microliters saline) [days, max to 30]',\n",
       " 'Immune system: ELISA-3x, IgG class antibody binding to TSHR A-subunit protein in ELISA 4 weeks after 3 immunizations with TSHR A-subunit adenovirus [OD490 nm]',\n",
       " 'Immune system, endocrinology: serum inhibition of TSH binding to the TSHR before immunization [% inhibition] ',\n",
       " 'Immune system, endocrinology: Serum inhibition of TSH binding to the TSHR 4 weeks after 3 immunizations with TSHR A-subunit adenovirus in young adult females [% inhibition]',\n",
       " 'Immune system, endocrine system: TBI-2x, serum inhibition of TSH binding to the TSHR 1 week after 2 immunizations with TSHR A-subunit adenovirus [% inhibition]',\n",
       " 'Immune system: ELISA-2x, IgG class antibody binding to TSHR A-subunit protein in ELISA 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus [OD 490 nm]',\n",
       " 'Infectious disease, immune system: Malaria infection lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old males and females (0 = 100% resistant, 1 = 100% susceptible) [fraction of cohort that survives]',\n",
       " 'Infectious disease, immune system: Ectromelia virus mortality score (combined data from Brownstein 1999 and Rice et al. 2010) [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale]',\n",
       " 'Infectious disease, immune system: Malaria susceptibility, murine Plasmodium yoelli 17X-lethal (PY17X-L) [0=100% resistant, 1= 100% susceptible]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 5 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 4 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 8 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 6 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 7 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 2 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 3 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 9 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 1 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 10 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 10 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 8 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 7 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 11 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), mean time to death after infection in 9-14 week-old females [days]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 11 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 12 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 13 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 9 after infection in 9-14 week-old females [%]',\n",
       " 'Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old females (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives]',\n",
       " 'Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC) in 7-12 week-old males (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives]',\n",
       " 'Infectious disease, immune system: TNFa cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL]',\n",
       " 'Infectious disease, immune system: MCP1 cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL]',\n",
       " 'Infectious disease, immune system: Interferon alpha (IFNa) cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL]',\n",
       " 'Infectious disease, immune system: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, ',\n",
       " 'Infectious disease, immune system: Ectromelia virus survival over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.33 days/unit]',\n",
       " 'Infectious disease, immune system: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of l',\n",
       " 'Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old females (1=resistant and 0= susceptible)[survival fraction]',\n",
       " 'Infectious disease, immune system: Ectromelia virus measure of disease onset measured by the day of maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex,',\n",
       " 'Infectious disease, immune system: Malaria susceptibility, murine Plasmodium yoelli 17 (PY17X-L) [0=resistant, 1= susceptible]',\n",
       " 'Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old males (1=resistant and 0= susceptible)[survival fraction]',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues, TAFI13',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI12',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI8',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI9',\n",
       " 'Infectious disease, immune system: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence ',\n",
       " 'Infectious disease, immune system: Ectromelia virus euthanasia scale over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [-1 is survival, +2 is rapid ',\n",
       " 'Infectious disease, immune system: Ectromelia virus survival over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.7 days/unit]',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI10',\n",
       " 'Infectious disease, immune system: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for s',\n",
       " 'Infectious disease, immune function: Ectromelia virus measure of disease onset, day of maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI11',\n",
       " 'Immune system, cardiovascular system: Peripheral blood lymphocytes, percentage of B cells [B220 %]',\n",
       " 'Immune system, cardiovascular system: Peripheral blood lymphocytes, percentage of CD8+ T cells [%]',\n",
       " 'Immune system, cardiovascular system: Peripheral blood lymphocytes, percentage of CD4+ T cells [%]',\n",
       " 'Infectious disease, immune system: Staphloccocus pyogenes (sq injection of 1.0x10x8 CFU) survival index in males and females injected at 10_¾_16 weeks of age (scored as follows: death before day 3 = 1, death from 3 to 7 = 2, death after day 7 =3) [index]',\n",
       " 'Immune system, cardiovascular system: Peripheral blood lymphocytes, CD4+/CD8+ T cell ratio, males at 3-5 month [ratio]',\n",
       " 'Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males only between 40 and 150 days of age, residuals corrected for age and body weight [presence of lesions',\n",
       " 'Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, females between 40 and 150 days of age, residuals corrected for age and body weight [presence of lesions wh',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI6',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI7',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections body weight change after infection corrected for strain, sex, age and body weight, day 4 [%]',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections body weight change after infection corrected for strain, sex, age and body weight, day 3 [%]',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections body weight change after infection corrected for strain, sex, age and body weight, day 2 [%]',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections survival after infection corrected for strain, sex, age and body weight given as corrected relative survival index [-1.5 = high',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections body weight change after infection corrected for strain, sex, age and body weight, day 1 [%]',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections lesion size after infection corrected for strain, sex, age and body weight given as maximum lesion area [Sq.mm]',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections body weight change after infection corrected for strain, sex, age and body weight given as principal component 1 of day 1 to da',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI3',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, virulence following corneal infection, young adult male and female (combined) [percent mortality]',\n",
       " 'Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 4 [% change in body weight]',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI1',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI5',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI4',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI2',\n",
       " 'Infectious disease, immune system: Cowpox virus survival over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [~2.67/unit]',\n",
       " 'Infectious disease, immune system: Immune response to bacterial LPS, polymorphonuclear macrophage after 4 hr acute, bronchial lavage [1000/ml]',\n",
       " 'Infectious disease, immune system, pulmonary system: Coccidioides immitis (Valley fever, San Joaquin California disease fungus, Coccidioidomycosis) susceptibility after an IP injection (500 - 800 CFU of the RS strain) in 7 to 12-week-old females, 10 per ',\n",
       " 'Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 2 [% change in body weight]',\n",
       " 'Infectious disease, immune system: Cowpox virus severity of disease measured by the maximum clinical score over two weeks after a 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age, and body',\n",
       " 'Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum clinical score over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age',\n",
       " 'Infectious disease, immune system: Cowpox virus maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled deg C where -0.5 is >',\n",
       " 'Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, a',\n",
       " 'Infectious disease, immune system: Cowpox virus maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight at time of inoculation [scaled % l',\n",
       " 'Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age an',\n",
       " 'Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 3 [% change in body weight]',\n",
       " 'Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss, first principal component, days 1-4 [% change in body weight]',\n",
       " 'Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 1 [% change in body weight]',\n",
       " 'Infectious disease, immune function: Chlamydia muridarum upper genital tract disease severity (endometrium, uterine horn) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe] ',\n",
       " 'Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, day of death [days]',\n",
       " 'Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, [1=resistant, 0=sensitive]',\n",
       " 'Infectious disease, immune function: Chlamydia muridarum upper genital tract disease severity (oviduct) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe disease] ',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes disease severity, corrected relative survival index (Fig 1A, residuals after correction for age, sex, body weight and log inoculum, with added strains BXD76 and BXD80) [-1 = high susceptible, +1 is',\n",
       " 'Infectious disease, immune function, pulmonary system: H1N1 (PR8) influenza A virus (2x10E3 FFU), viral PB2 gene expression in lung of individual mice used in companion RNAseq experiment (see HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) [log2 RPKM',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI14',\n",
       " 'Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI15',\n",
       " 'Infectious disease, immune function, pulmonary system: H1N1 (PR8) influenza A virus (2x10E3 FFU), viral PB1 gene expression in lung of individual mice used in companion RNAseq experiment (see HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) [log2 RPKM',\n",
       " 'Infectious disease, immune function, pulmonary system: H1N1 (PR8) influenza A virus (2x10E3 FFU), viral NS gene expression in lung of individual mice used in companion RNAseq experiment (see HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) [log2 RPKM]',\n",
       " 'Infectious disease, immune function, pulmonary system: H1N1 (PR8) influenza A virus (2x10E3 FFU), viral NP gene expression in lung of individual mice used in companion RNAseq experiment (see HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) [log2 RPKM]',\n",
       " 'Infectious disease, immune function, pulmonary system: H1N1 (PR8) influenza A virus (2x10E3 FFU), viral NA gene expression in lung of individual mice used in companion RNAseq experiment (see HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) [log2 RPKM]',\n",
       " 'Infectious disease, immune function, pulmonary system: H1N1 (PR8) influenza A virus (2x10E3 FFU), viral M gene expression in lung of individual mice used in companion RNAseq experiment (see HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) [log2 RPKM]',\n",
       " 'Infectious disease, immune function, pulmonary system: H1N1 (PR8) influenza A virus (2x10E3 FFU), viral HA gene expression in lung of individual mice used in companion RNAseq experiment (see HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) [log2 RPKM]',\n",
       " 'Immune system, pulmonary system: Tumor necrosis factor (TNF)-alpha level in lung after aerosolized lipopolysaccharide (LPS) exposure [pg/ml]',\n",
       " 'Infectious disease, immune function: Cowpox virus disease onset measured by day of max clinical score over three weeks after 10^5pfu intranasal infection, males and females between XX and XXX days of age, residuals corrected for age, sex and body weight [',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult female and male [max weight loss %]',\n",
       " 'Immune system, pulmonary system: Polymorphonuclear leukocyte number (PMN) after aerosolized LPS exposure [PMN/ml (x103)]',\n",
       " 'Immune function: CD62L+ cells as a percentage of CD3+ CD4+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: Ly6C+ cells as a percentage of CD3+ CD4+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD44+ cells excluding CD62L cells as a percentage of CD8+ CD3+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: IgD+ cells as a percentage of B cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: Gr-1-NKp46- CD11b+ as a percentage of CD45+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD3+CD8a+ cells as a percentage of CD45+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD3+ gamma/delta TCR+ cells as a percentage of CD45+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: GR-1+ CD11b+ cells as a percentage of CD45 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD62L+ cells excluding CD44 cells as a percentage of CD3+CD8+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: Ly6C+ cells as a percentage of CD3+ CD8+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD44+ Ly6C+ cells as a percentage of CD3+ CD8+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD62L+ cells as a percentage of CD3+ CD8+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD3+CD4+ cells as a percentage of CD45+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD44+ cells as a percentage of CD3+ CD8+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD3+ cells as a percentage of CD45+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD44+ effector-memory T cells as a percentage of CD3+ CD4+ T cells in peripheral blood measured by fluorescence activated cell sorting (this trait maps to CD44 locus) (FACS) [%]',\n",
       " 'Immune function:CD5+ cells as a percentage of B cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD44+ cells as a percentage of CD3+ CD4+ without CD62L cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD62L+ T cells without CD44 cells as a percentage of CD3+ CD4+ T cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: B cells as a percentage of MHC class II (I/A-E) cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: CD25+ cells as a percentage of CD3+ CD4+ in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Infectious disease, immune system: Please put in a full description of the phenotype here with sex, age, innoculum, dose, route and at the end in square brackets the [units]deltaD2-D1_colo_Russo',\n",
       " 'Infectious disease, immune system: Please put in a full description of the phenotype here with sex, age, innoculum, dose, route and at the end in square brackets the [units] 3_colo_Russo ',\n",
       " 'Immune system, hematology: CD11b+ NKp46+ cells as a percentage of CD5-cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: B cells (CD19 or B220 and IgD) as a percentage of CD45+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune function: Nkp46+ cells as a percentage of CD45 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]',\n",
       " 'Immune system, metabolism: Iron level in spleen of males [ug/g]',\n",
       " 'Infectious disease, immune system: Burkholderia pseudomallei (126b) infection response (50 CFU intranasal), survival in males, [1=resistant, 0=sensitive]',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult male [max weight loss %]',\n",
       " 'Immune system, metabolism: Iron level in spleen of males and females [ug/g]',\n",
       " 'Immune system, aging: Hematopoietic stem cell and progenitor cell number (lin-Sca1++ c-kit+ cells) from femur bone marrow of females a 18 months (confirm) (unpublished additional data) [n cells]',\n",
       " 'Immune system, metabolism: Iron level in spleen of females [ug/g] ',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection) sepsis bacteremia 24 h post-infection corrected for age, sex, body weight, log inoculum (Fig 1B) [corrected log CFU/ml]',\n",
       " 'Immune system, aging: Progenitor cell proliferation in young mice (2 months of age), effect of TGFB2 (0.1 ng/ml) on the proliferation of lin-Sca1++kit+ cells relative to control without TGFB2 [%]',\n",
       " 'Infectious disease, immune system: Bronchoalveolar lavage (BAL) lung lymphocyte cell number following infection with Acinetobacter baumannii [units/ul]',\n",
       " 'Immune system, aging: Percentage of hematopoietic stem cells and progenitor cells in femur bone marrow (lin-Sca1++ c-kit+) at 18 months of age (Figure 2B of paper) [%]',\n",
       " 'Immune system, aging: Percentage of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow [%]',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, percent maximum weight loss following corneal infection, young adult female (combined) [max weight loss %]',\n",
       " 'Immune system, aging: Hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow (Fig 2A of paper) [n per well]',\n",
       " 'Infectious disease, immune system: Acinetobacter baumannii infection, bronchoalveolar lavage (BAL) lung lymphocyte cell number following (BXD65 winsorized from 47.5 to 26.0) [units/ul]',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, stromal keratitis severity following corneal infection, young adult male and female (combined) [ordinal 1 t0 5 scale, 0=none, 5 = penetrating lesions]',\n",
       " 'Immune system, hematopoesis, aging: Hematopoietic stem cells and progenitor cells, numbers of Lin-Sca1++ cells at 2 months of age in females (Figure 3B of paper) [n]',\n",
       " 'Immune system, hematopoesis, aging: Hematopoietic stem cell and progenitor cell proliferative capacity (Lin-Sca1++ cells from femur bone marrow), in vitro assay of cells from 2-3 month old females in response to KL, flt3L, and TPO (Figure 3A of paper) [n ',\n",
       " 'Infectious disease, immune system: Sendai virus lethality with 1.0 TCID50 [% mortality]',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes disease severity, corrected relative survival index (differs from Fig 1A slightly, residuals after correction for age, sex, body weight and log inoculum, with added strain BXD80) where -1 means hig',\n",
       " 'Infectious disease, immune system: Ectromelia virus-induced mortality [3 = resistant, 1 = both intermediate and susceptible, ordinal scale]',\n",
       " 'Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection) dissemination to spleens, 24 h post-infection (Fig 1C) [CFU/ml]',\n",
       " 'Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-7 positive, Vgamma-4 positive T cells) [%]',\n",
       " 'Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-1 positive, Vgamma-4 negative T cells) from Fig 4 x-axis [%]',\n",
       " 'Immune system, aging: Stem cell frequency, cobblestone area-forming cell assay count (CAFC) on day 35 [CAFC per 10e5 bone marrow cells]',\n",
       " 'Immune system, aging: Proliferative activity of hematopoietic stem cells on day 7 in culture [% CAFC]',\n",
       " 'Immune system, aging: Hematopoietic stem cell number (cobblestone-area-forming cells per femur at 35 days of age from 3 females, also previously published) [n]',\n",
       " 'Immune system, hematopoesis, aging: Relative fraction of hematopoietic stem cells and progenitor cells (Lin-Sca1++) from bone marrow in 2-3 month old females (Figure 3C of paper) [%]',\n",
       " 'Infectious disease, immune system: Myoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection gross pulmonary lesions [burden]',\n",
       " 'Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-7 positive, Vgamma-4 negative T cells) from Fig 4 y-axis [%]',\n",
       " 'Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-1 positive, Vgamma-4 positive T cells) [%]',\n",
       " 'Infectious disease, immune system: Ectromelia virus-induced mortality in males [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale]',\n",
       " 'Immune system, aging: Hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow (additional data not included in paper) [n cells total]',\n",
       " 'Infectious disease, immune system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU), fraction dead 21 days after infection [ratio]',\n",
       " 'Immune system: TRBV4+ T cell levels among CD8+ T cells in spleen [%]',\n",
       " 'Infectious disease, immune system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway lymphoid hyperplasia',\n",
       " 'Infectious disease, immune system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway exudate [units]',\n",
       " 'Infectious disease, immune system, pulmonary system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway epithelial hyperplasia',\n",
       " 'Infectious disease, immune system: EOMES coefficient (Malak Kotb and colleagues 2014) Please provide a full description of the trait now here with information on sex, age range, innoculum, route of infection etc. [units]',\n",
       " 'Infectious disease, immune function: Please enter the full trait description here even BEFORE publication. Only you will see these descriptions.',\n",
       " 'Infectious disease, immune system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, alveolar exudate [units]',\n",
       " 'Immune system, infectious disease: Rickettsiu tsutsugamushi susceptibility (strain Gilliam, ip 100 50% mouse infectious doses, two treatments) of both sexes at 6-12 weeks-of-age (ordinal scale 0 = resistant, 1=susceptible, also see BXH RI set), maps to Gb',\n",
       " 'Immune system: TRBV4+ T cell levels among CD8+ T cells in peripheral blood [%]',\n",
       " 'Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in heart 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)]',\n",
       " 'Immune system: Tumor necrosis factor (TNF) lethality after injection [%]',\n",
       " 'Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), survival index at 11 days in 2-4 month males [mean score, 0=resistant, 1=weight loss and all survive, 2=weight loss some survive, 3=no survival]',\n",
       " 'Immune system: Proliferation of T cell clone (JTL-G12.8 clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]',\n",
       " 'Immune system: Proliferation of T cell clone (JTL-G12.8 clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]',\n",
       " 'Immune system: Proliferation of T cell clone (JTL-G12 clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]',\n",
       " 'Immune system: Proliferation of T cell clone (JTL-G12 clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]',\n",
       " 'Infectious disease, immune system, liver: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in liver 48 h after infection of 10E5 CFU in 10-14 old females [CFU (log10)]',\n",
       " 'Infectious disease, immune system, urogenital system, kidney: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in kidney 48 h after infection of 10E5 CFU in 10-14 old females [CFU (log10)]',\n",
       " 'Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in blood 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)]',\n",
       " 'Immune system, aging: Proliferative capacity in vitro of bone marrow stem and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age in response to KL, flt3L and TPO (figure 2C of paper) [n cells]',\n",
       " 'Immune system: Thymic T-cell proliferative unresponsiveness (anergy) to anti-CD3-induced proliferation (chemokine-associated) [units]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) footpad swelling, 3 weeks post infection in females (BXD80 winsorized from 196 to 120) [% of C57BL/6 control]',\n",
       " 'Immune system: lymphocyte major glycoprotein (gp70) xenotropic leukemia virus envelope-related cell-surface antigen (XenCSA) level measured as mean fluorescence value (sum of products of each channel number times the number of spleen cells in that channel',\n",
       " 'Lung, immune system: Airway bronchial constrictor response after exposure to atracurium, airway pressure time index [cmH2O/s]',\n",
       " 'Infectious disease, immune system: Log Day 1 of counts of E coli colonization in BXD strains colon after infection with 109 cfu of E. coli strain O157:H7, isolate Tuv 86-2 (Stx2-), intra-gastric gavage, female mice, 5_¾_7 weeks old [CFU/g feces]',\n",
       " 'Infectious disease, immune system: xenotropic MuLV envelope-related cell-surface antigens (XenCSA) levels on thymus cells measured as mean fluorescence value (sum of products of each channel number times n cells in that channel divided by n cells counted)',\n",
       " 'Infectious disease, immune function: Susceptibility to Staphylococcus aureus, mean time of death in days of mice infected with 10E5 colony forming units (CFU) per mouse in 10-14 old females [days]',\n",
       " 'Infectious disease, immune function: Susceptibility to Staphylococcus aureus, % survival after 4 days of mice infected with 10E5 colony forming units (CFU) per mouse in 10-14 old females [%]',\n",
       " 'Infectious disease, immune function: Susceptibility to Staphylococcus aureus, survival 10 days after infection with 10E5 colony forming units (CFU) in 10 to 14 day-old females [%]',\n",
       " 'Immune system, morphology, nutrition: Spleen weight of 120-day-old males and females fed 3 ppm Fe diet [g]',\n",
       " 'Immune system: Phenyloxazolone hapten-induced Igh-Ox antibody marker level (public idiotype)[units]',\n",
       " 'Immune system, development: Hematopoietic stem cell pool size, cobblestone area-forming cells per 100,000 bone marrow cells [n]',\n",
       " 'Immune system: Granulocyte colony stimulating factor (G-CSF) induced progenitor cell mobilization from bone marrow to blood [PB-CFC/ul]',\n",
       " 'Immune system, morphology, nutrition: Iron level in spleen of 120-day-old females fed 3 ppm Fe diet [ug/g]',\n",
       " 'Immune system, metabolism, nutrition: Iron level in spleen of 120 day old males and females fed 3 ppm Fe diet [ug/g]',\n",
       " 'Immune system: V beta 3+ T cells in lymph nodes [%]',\n",
       " 'Infectious disease, immune system: Murine cytomegalovirus (MCMV) titer in spleen 4 days after infection with 5X10^4 PFU (KLRA complex) [log10 burden]',\n",
       " 'Immune system, morphology, nutrition: Spleen weight of 120-day-old females fed 3 ppm Fe diet [g]',\n",
       " \"Toxicology, cancer biology: Skin tumors after initiation with N-methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate [n per case]\",\n",
       " 'Immune system, morphology, nutrition: Iron level in spleen of 120-day-old females fed 270 ppm Fe diet [ug/g]',\n",
       " 'Immune system, morphology, nutrition: Spleen weight of 120-day-old males fed 3 ppm Fe diet [g]',\n",
       " 'Immune system, morphology, nutrition: Spleen weight of 120-day-old males and females fed 270 ppm Fe diet [g]',\n",
       " 'Immune system, metabolism, nutrition: Iron level in spleen of 120 day old males and females fed 270 ppm Fe diet [ug/g]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), parasite burden in feet 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Cancer biology, liver, toxicology: Hepatocellular carcinoma tumor multiplicity in liver of males after infection with 0.01 ml/g body wt N,N-diethylnitrosamine [n]',\n",
       " \"Toxicology, cancer biology: Skin tumor incidence following initiation with N-Methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate [% mice]\",\n",
       " 'Immune system, morphology, nutrition: Spleen weight of 120-day-old females fed 270 ppm iron (Fe) diet [g]',\n",
       " 'Immune system, metabolism, nutrition: Iron level in spleen of 120 day old males fed 3 ppm Fe diet [ug/g]',\n",
       " 'Cancer biology, liver, toxicology: Hepatocellular carcinoma tumor multiplicities induced by N,N-diethylnitrosamine (DEN 0.01 ml/g, ip at postnatal day 12), mean tumor multiplicity in liver at 32 weeks in male [n]',\n",
       " 'Immune system, morphology: Spleen weight, splenomegaly induced by Bacillus Calmette_¾_Gu\\x90©rin tuberculosis vaccine (iv injection in oil and saline) (BCG) [mg]',\n",
       " 'Infectious disease, immune system, pulmonary system: Lung inflammatory response, pulmonary granulomatous inflammation induced by Bacillus Calmette_¾_Gu\\x90©rin tuberculosis vaccine (BCG) [units]',\n",
       " 'Infectious disease, immune system, protein: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), tumor necrosis factor alpha level (TNFA, Chr 17 at 35 Mb) from draining lymph node 3 weeks post infection in females using Luminex assay ',\n",
       " 'Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as tumor necrosis factor alpha (TNFa) cytokine expression [pg/ml]',\n",
       " 'Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interferon gamma (IFNG) cytokine expression [ng/ml/]',\n",
       " 'Infectious disease, immune system: Anergy measured by footpad thickness resulting from BCG injection [mm]',\n",
       " \"Infectious disease, immune system: Theiler's murine encephalomyelitis virus (TMEV) spinal cored demyelination susceptibility (excludes strains with B allele at H2 locus) [% affected]\",\n",
       " 'Immune system: Tumor necrosis factor (TNF) lethal shock, induction of serum interleukin 6 (IL-6) cytokine after injection [ng/ml]',\n",
       " 'Immune system, metabolism: Tumor necrosis factor (TNF)-induced hypothermia [degree C]',\n",
       " 'Immune system, aging: Proliferative capacity, number of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) after treatment with transforming growth factor beta 2 (TGFB2, 0.01 ng/ml) at 18 months of age (confirm) (unpublished additiona',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male and female (combined) [g]',\n",
       " 'Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interleukin 6 (IL-6) cytokine expression [pg/ml]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), vascular endothelial growth factor (VEGF) level from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Immune system, morphology, nutrition: Spleen weight of 120-day-old males fed 270 ppm Fe diet [g]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-3 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-5 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-6 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Immune system, metabolism, nutrition: Iron level in spleen of 120 day old males fed 270 ppm Fe diet [ug/g]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-13 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-17 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) IP-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), chemokine (C-X-C motif) ligand 1 level (CXCL1, KC, Chr 5 at 91 Mb) from draining lymph node 3 weeks post infection in females [% of C57BL/6 contro',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) LIF from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major response (footpad injection, 5 million promastigotes at 7 weeks), monocyte chemoattractant protein-1 (MCP1) level from draining lymph nodes 3 weeks after infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major response (footpad injection, 5 million promastigotes at 7 weeks), macrophage inflammatory protein-1 beta (MIP1B) from draining lymph nodes 3 weeks after infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) MIG alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) RANTES from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-4 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune function: Leishmania major (footpad injection of 5 million promastigotes at 7 weeks) granulocyte macrophage colony-stimulating factor (GM-CSF) level from draining lymph node, 3 weeks after infection in females (Luminex assay) [%',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) Interferon-gamma from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), interleukin-1 beta level (IL1B, Chr 2 at 129 Mb) from draining lymph node 3 weeks post infection in females [%of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]',\n",
       " 'Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), granulocyte colony-stimulating factor (G-CSF, CSF3, Chr 11 at 98.6 Mb) from draining lymph node 3 weeks post infection in females [%of C57BL/6 con',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, anti-DNA antibodies sera titers, 13 month females (Fig 7 from Mountz et al., 2005) [natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4, ln of 0',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male [g]',\n",
       " 'Infectious disease, immune function: Linear bacterial load in liver 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [linear CFU / liver / 10]',\n",
       " 'Infectious disease, immune function: Lung weight/body weight 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [lung weight/body weight * 10000]',\n",
       " 'Infectious disease, immune function, pulmonary system: Bacterial load in lungs 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [log10 CFU / lung * 100]',\n",
       " 'Immune system, aging: Proliferative capacity, effect of TGF-beta2 stimulation (0.1 ng/ml) on numbers of lin-Sca1++ c-kit+ cells (unpublished additional data) [% increase]',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of generalized autoimmunity measured as ratio of Ig to rheumatoid factor (RF) in 13-month-old mice [ratio, natural log of total Ig to RF (ELISA OD 450 x 10^4)]',\n",
       " 'Immune system, aging: Proliferative activity of hematopoietic stem cells, day 21 cobblestone area forming cell (CAFC) frequency change [% CAFC]',\n",
       " 'Immune system, aging: Proliferative activity of hematopoietic stem cells, change in quiescent HSC percentage (cobblestone area-forming cells day 35 of culture) at 20 months [% CAFC]',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgM-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]',\n",
       " 'Immune system, aging: Stem cell cycling, change in day 7 cobblestone area forming cell (CAFC) frequency during aging [%CAFC]',\n",
       " 'Immune system, aging: Proliferative activity of hematopoietic stem cells, quiescent HSCs in aged mice, cobblestone area forming cells (CAFC) on day 35, frequency in bone marrow [CAFC per 10e5 bone marrow cells]',\n",
       " 'Immune system, aging: Proliferative activity of hematopoietic stem cells, quiescent stem cells in aged mice, cobblestone area forming cells (CAFC) at day 35 in culture, frequency in bone marrow [CAFC per 10e5 bone marrow cells]',\n",
       " 'Infectious disease, immune function: Linear bacterial load in spleen 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [linear CFU / spleen / 100]',\n",
       " 'Infectious disease, immune system: LacZ expression 21 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]',\n",
       " 'Infectious disease, immune system, pulmonary system: Mycobacterium tuberculosis (H37Rv, 100 colony forming units (CFU)) response, bacterial load in lung 21 days after aerosol infection in 12-23 week-old females [linear CFU/lung/1000]',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2b-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]',\n",
       " 'Infectious disease, immune system: Autoimmune disease, rheumatoid factor sera titers, 13 month females (natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4)',\n",
       " 'Infectious disease, immune system: Cytotoxicity in spleen T cells 50 days post 5x109 PFU AdLacZ i.v injection [%]',\n",
       " 'Infectious disease, immune system: Cytotoxicity in spleen T cells 30 days post 5x109 PFU AdLacZ i.v injection [%]',\n",
       " 'Infectious disease, immune system: Cytotoxicity in spleen T cells 21 days post 5x109 PFU AdLacZ i.v injection [%]',\n",
       " 'Infectious disease, immune system: Cytotoxicity in spleen T cells 7 days after 5x109 PFU AdLacZ i.v injection [%]',\n",
       " 'Infectious disease, immune system: LacZ expression 50 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]',\n",
       " 'Infectious disease, immune system: LacZ expression 30 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2a-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2b-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]',\n",
       " 'Infectious disease, immune system: LacZ expression 7 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of IgM-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG1-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2a-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]',\n",
       " 'Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), weight loss ratio at 11 days compared to baseline in 2-4 month males [ratio]',\n",
       " 'Infectious disease, immune system: Tuberculosis, bacterial load in lung (BXD71 winsorized from 4.18 to 4.98) [log CFU]',\n",
       " 'Immune system, morphology, aging: Thymus involution, age-related rate of decline measured as involution slope (-beta 1x10^4)',\n",
       " 'Immune system, morphology, aging: Thymocyte count in young adult mice, initial [Beta 0]',\n",
       " 'Immune system, morphology, aging: Thymocyte count, projected at 60 days [units]',\n",
       " 'Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), body weight loss day 3 after infection in 9-14 week-old females [%] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM)',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of generalized Ig to anti-DNA in 13-month-old mice [natural log of total Ig to anti-DNA (ELISA OD 450 x 10^4)]',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult female [g]',\n",
       " 'Infectious disease, immune system, pulmonary system: Tuberculosis, bacterial load in lung [CFU]',\n",
       " 'Infectious disease, immune system: Salmonella typhimurium bacterial strain LT2-Z growth from livers and spleens 6 days post inoculation with 10^2 CFU (figure 3, filled circles) [log10 CFU]',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult females [unit]',\n",
       " 'Infectious disease, immune function: Linear bacterial load in spleen 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [linear CFU / spleen / 1000]',\n",
       " 'Immune system, morphology: Thymus to body size ratio [x10^3]',\n",
       " 'Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG1-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]',\n",
       " 'Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, day 0 baseline [ELISA OD 450]',\n",
       " 'Immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 14 [ELISA OD 450]',\n",
       " 'Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) immune response following injection of 3xE11 vector genomes vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, on day 42 [ELISA OD 450]',\n",
       " 'Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 120 [ELISA OD 450]',\n",
       " 'Infectious disease, immune system: Salmonella typhimurium bacterial strain WB500 from livers and spleens 6 days post inoculation with 10^2 CFU (figure 3 open circles) [log10 CFU]',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, serum neutralization titer following corneal infection, young adult male and female (combined) [unit]',\n",
       " 'Infectious disease, immune function: Linear bacterial load in lung 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [linear CFU / lung / 10000]',\n",
       " 'Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3xE11 vector genomes (vg) /mouse AAV2-(ApoE)4/hAAT-cF.IX on day 180 [ELISA OD 450]',\n",
       " 'Infectious disease, immune function: Linear bacterial load in liver 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [linear CFU / liver / 100]',\n",
       " 'Infectious disease, immune function: Quantity of lung pathology 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [quantitative score (10 lowest - 70 highest)]',\n",
       " 'Infectious disease, immune function: Quantity of lung pathology 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [quantitative score (10 lowest - 70 highest)]',\n",
       " 'Infectious disease, immune function: Lung weight/body weight 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [lung weight/body weight * 10000]',\n",
       " 'Infectious disease, immune function: Bacterial load in lungs 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [log10 CFU / lung * 100]',\n",
       " 'Infectious disease, immune function: Normalized bacterial load in lungs 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [ratio CFU BXD / CFU C57BL/6J * 100]',\n",
       " 'Infectious disease, immune function: Quality of lung pathology 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [ordinal scale (10 = normal, 20 = intermediate, 30 = severe)]',\n",
       " 'Immune system, aging: Proliferative capacity change, difference between old (18 months) and young (2 months) on number of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) after treatment with transforming growth factor beta 2 (TGFB2',\n",
       " 'Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), pathogen load in peritoneal cavity at 30 days among surviving 3-5 month males (subset of cases) [log ng of DNA] ',\n",
       " 'Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult males [unit]',\n",
       " 'Infectious disease, immune system: Salmonella typhimurium bacterial strain SR-11, net growth in livers and spleens 6 days after inoculation with 10^2 CFU (figure 5, triangles, Itk/Nramp1/Slc11a1-associated) [log10 CFU]',\n",
       " 'Immune system, environmental toxicology: Airway inflammatory response to ozone (2 ppm for 3 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after acute exposure [number of PMNs x10^3]',\n",
       " 'Immune system, pulmonary system, environmental toxicology: Airway inflammatory response to ozone (0.30 ppm for 48 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after exposure [n PMNs x10^3]',\n",
       " 'Immune system, urogenital system, kidney: Immune complex deposits in kidney immunized with the 16/6 Id [0=no immune complexes; 1=1-5 immune complex deposits; 2=5-20 immune complex deposits; 3=20-50 immune complex deposits; 4=50 immune complex deposits]',\n",
       " 'Immune system, hematopoesis, aging: Hematopoietic stem cells and progenitor cells in femur bone marrow, percentage of c-kit-postiive cells to c-kit-ngative cells among Lin-Sca1++ cells in 2-month old femaies (Figure 3d of paper) [%]',\n",
       " 'Infectious disease, immune system: IgG1 isotype-specific anti-cF.IX (coagulation Factor IX) response following injection of 3e11 vg/mouse AAV2-cF.IX [ELISA OD 450 (x 10^4)]',\n",
       " 'Immune function: Antibody IgG1 response following iv injection of canine coagulation factor IX (cF.IX, 3E11 vg/mouse) [ng/ml]',\n",
       " 'Infectious disease, immune system, morphology: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), spleen weight at 30 days among surviving animals, 2-4 months males (subset of cases from Miyiari 2007) [gm]',\n",
       " \"Infectious disease, immune system: Theiler's murine encephalomyelitis virus (TMEV, dermal injection), delayed-type hypersensitivity (DTH) response measured as ear swelling [inch x 1E-3]\",\n",
       " 'Cancer biology: Growth of syngeneic breast cancer tumors day 25 [mm3]',\n",
       " 'Cancer biology: Necrosis of implanted breast tumor [n]',\n",
       " 'Cancer biology: Syngeneic breast tumor growth, number of cases with tumor metastasis [n]',\n",
       " 'Cancer biology: Syngeneic breast cancer tumor growth, day 5 [mm3]',\n",
       " 'Cancer biology: Growth of syngeneic breast cancer tumors day 10 [mm3]',\n",
       " 'Cancer biology: Growth of syngeneic breast cancer tumors day 15 [mm3]',\n",
       " 'Cancer biology: Syngeneic breast cancer tumor growth, day 20 [mm3]',\n",
       " 'Cancer biology: Metastasis of implanted breast tumor in lymph node, cases with tumor metastasis [n]',\n",
       " 'Cancer biology: Metastasis of implanted breast tumor in pancreas, cases with tumor metastasis [n]',\n",
       " 'Infectious disease, immune function: Median survival time in log10 after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [days in log10 * 100]',\n",
       " 'Immune system, aging: T-cell proliferative response (age-related decline), concavalin-A induced thymic T-cell response at 22-month-old in females (average of days 2 and 4)[unit]',\n",
       " 'Immune system, aging: Age-related T-cell decline, percentage of CD4-negative CD8-negative DN cells in thymus [%]',\n",
       " 'Immune system, aging: Age-related T-cell decline, percent of CD4-CD8 double positive cells in thymus [%]',\n",
       " 'Immune system, aging: T-cell decline during aging, percentage of CD25-negative/CD44-positive double negative (CD4(-)CD8(-)) cells in thymus at 22 months [%]',\n",
       " 'Immune system, aging: Age-related T-cell decline, percentage of CD25-positive CD44-negative DN cells in thymus [%]',\n",
       " 'Immune system, aging: Age-related T-cell decline, percentage of CD25-CD44 double negative thymocytes at 22 months in females [%]',\n",
       " 'Infectious disease, immune function: Normalized median survival time after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [ratio survival time BXD / survival time C57BL/6J * 100]',\n",
       " 'Infectious disease, immune function: Mean moribund body weight after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [g * 10]',\n",
       " 'Infectious disease, immune function: Mean moribund temperature after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [deg C * 10]',\n",
       " 'Immune system, cancer: Resistance to lymphoma tumors induced by ESb DBA/2 (H-2d) cell transplant [%]',\n",
       " 'Infectious disease, immune function, pulmonary system: H1N1 (PR8) influenza A virus (2x10E3 FFU), viral PA gene expression in lung of individual mice used in companion RNAseq experiment (see HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) [log2 RPKM]',\n",
       " 'Infectious disease, immune function: MCP-1 (CCL2 or monocyte chemotactic protein-1) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]',\n",
       " 'Infectious disease, immune system: Herpes simplex virus 1 (HSV-1) ocular pathogenesis, please add details on sex, innoculum, age, etc here [units]',\n",
       " 'Infectious disease, immune function: locomotor activity during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]',\n",
       " 'Infectious disease, immune function: locomotor activity during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline]',\n",
       " 'Infectious disease, immune function: locomotor activity during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline]',\n",
       " 'Infectious disease, immune function: Temperature during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C]',\n",
       " 'Infectious disease, immune function: Temperature during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C]',\n",
       " 'Infectious disease, immune function: Mean temperature 13 weeks after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 13-30 week-old females [deg C * 10]',\n",
       " 'Infectious disease, immune system, urogenital system: TNF-a at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney] ',\n",
       " 'Infectious disease, immune function: KC (CXCL1; keratinocyte-derived chemokine at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]',\n",
       " 'Infectious disease, immune function: MIP-2 (macrophage inflammatory protein 2-alpha or CXCL2) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]',\n",
       " 'Infectious disease, immune system: IP-10 (Interferon gamma-induced protein 10 or CXLC10) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [pg/mg protein, kidney] ',\n",
       " 'Infectious disease, immune system: G-CSF (granulocyte colony stimulating factor) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]',\n",
       " 'Infectious disease, immune system: Interleukin-6 (IL-6) protein level in kidney 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein]',\n",
       " 'Infectious disease, immune system: lipocalin-2 (LCN-2) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]',\n",
       " 'Infectious disease, immune system, urogenital system: Candida albicans titer in kidney (log) at 72 h after inoculation with 1 x 10^6 cfu (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue]',\n",
       " 'Infectious disease, immune system, central nervous system: Candida albicans titer in brain at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue]',\n",
       " 'Infectious disease, immune function: Serum glucose (unfasted) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [mg/dL serum)',\n",
       " 'Infectious disease, immune function: locomotor activity during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]',\n",
       " 'Infectious disease, immune function: temperature during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset (difference from baseline, C)',\n",
       " 'Infectious disease, immune function: locomotor activity during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]',\n",
       " 'Infectious disease, immune system, urogenital system: TNF-a (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney] ',\n",
       " 'Infectious disease, immune system: Locomotor activity 60-72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]',\n",
       " 'Infectious disease, immune function: Linear median survival time after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [days]',\n",
       " 'Infectious disease, immune system: Locomotor activity (log) during h 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]',\n",
       " 'Infectious disease, immune function: locomotor activity (log) during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]',\n",
       " 'Infectious disease, immune function: locomotor activity (log) during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]',\n",
       " 'Infectious disease, immune function: locomotor activity (log) during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]',\n",
       " 'Infectious disease, immune function: locomotor activity (log) during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline. log]',\n",
       " 'Infectious disease, immune system, morphology: Body weight 13 weeks after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 13-30 week-old females [g]',\n",
       " 'Infectious disease, immune function: MIP-2 (macrophage inflammatory protein 2-alpha or CXCL2) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidn',\n",
       " 'Infectious disease, immune system, protein expression: Lipocalin-2 (LCN-2) level in kidney 72 h after inoculation with 1 x 10^6 CFU Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [log pg/mg protein]',\n",
       " 'Infectious disease, immune system: IP-10 (Interferon gamma-induced protein 10 or CXLC10) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [pg/mg protein, log, kidney] ',\n",
       " 'Infectious disease, immune function: KC (CXCL1; keratinocyte-derived chemokine) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]',\n",
       " 'Infectious disease, immune system: IL-6 (interleukin-6) protein level in kidney 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [log pg/mg protein]',\n",
       " 'Infectious disease, immune function: G-CSF (granulocyte colony stimulating factor) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]',\n",
       " 'Infectious disease, immune function: MCP-1 (CCL2 or monocyte chemotactic protein-1) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]',\n",
       " 'Cancer biology: Syngeneic breast cancer tumor growth at day 30 [mm3]',\n",
       " 'Infectious disease, immune function: locomotor activity (log) during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline, log]',\n",
       " 'Infectious disease, immune function: Temperature during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C]',\n",
       " 'Infectious disease, immune function: Temperature during h 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus ; immediately after light onset [difference from baseline, C]',\n",
       " 'Infectious disease, immune function: Weight loss after Francisella tularensis live vaccine strain (FTLVS) intratracheal [slope]',\n",
       " 'Infectious disease, immune system: Survival after Francisella tularensis live vaccine strain (FTLVS) intratracheal [coefficient]',\n",
       " 'Infectious disease, immune system, urogenital system: Candida albicans titer, renal, at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [CFU x 10^4 per gram tissue we',\n",
       " 'Infectious disease, immune function: Temperature during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset (difference from baseline, C) ',\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Mice were analyzed 20hrs after the last exposure. Flow cytometry was performed and the % of BtcR+ cells in \",\n",
       " 'Infectious disease, immune system, central nervous system: Candida albicans titer in brain (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue ',\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Mice were analyzed 20hrs after the last exposure. Flow cytometry was performed on the BAL cells and PMNs we\",\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Mice were analyzed 20hrs after the last exposure. Flow cytometry was performed and the % of CD4+/BTcR+ cell\",\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Mice were analyzed 20hrs after the last exposure. Flow cytometry was performed on the BAL cells and gated o\",\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Mice were analyzed 20hrs after the last exposure. Flow cytometry was performed on the BAL cells and gated o\",\n",
       " 'Infectious disease, immune function: Weight loss after Francisella tularensis live vaccine strain (FTLVS) intratracheal [percent]',\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Mice were analyzed 20hrs after the last exposure. Flow cytometry was performed on the BAL cells and gated o\",\n",
       " 'Cancer biology: Leukocyte infiltration in metastatic breast tumor on day 12 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and 4 means most severe destruction) [index]',\n",
       " 'Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone D9 [thymidine uptake cpm]',\n",
       " 'Infectious disease, immune system: Leishmania L. mexicana skin lesion diameter in females [mm]',\n",
       " 'Cancer biology: Syngeneic breast cancer tumor growth, day 35 [mm3]',\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Flow cytometry was performed on the BAL cells from male mice and gated on CD8+/bTcR+/CD69+ expressed as %. \",\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), CD8+ T cell in bronchioalveolar lavage (BAL) samples 20 hours after last exposure exposure [%]\",\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Mice were analyzed 20hrs after the last exposure. Flow cytometry was performed on the BAL cells in males \",\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Mice were analyzed 20hrs after the last exposure. Flow cytometry was performed on the BAL cells and gated o\",\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), T cells in bronchioalveolar lavage (BAL) samples 20 hours after last exposure exposure in males (BXD32 wins\",\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease) and analyzed 20hrs after the last exposure. Neutrophils were identified by flow cytometry and analysis of F\",\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Mice were analyzed 20hrs after the last exposure. Alveolitis was measured by cell counting using trypan blu\",\n",
       " 'Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells on day 1 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and 4 means most severe destruction) [index]',\n",
       " 'Immune system: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone E4.3 [thymidine uptake cpm]',\n",
       " 'Infection disease, immune function: Cox-Hasty trait 1',\n",
       " 'Immune system: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone TGVH 9 [thymidine uptake cpm]',\n",
       " 'Immune system: Antigenic activity of irradiated BXD spleen cells for Thy1+CD3+CD4+CD8- T-cell clone TGVH32 [thymidine uptake, cpm]',\n",
       " 'Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4-CD8+ H-2(d) specific T-cell clone F10 ECK [thymidine uptake cpm]',\n",
       " 'Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone (11.1B/c) [thymidine uptake cpm]',\n",
       " 'Immune system: Anti-F antigen (liver protein) titer, experiment 2, log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen [log binding]',\n",
       " 'Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- Mls(a) specific T-cell clone F5J10 [thymidine uptake cpm]',\n",
       " 'Immune system, morphology: Thymus weight of females after 7 weeks of chronic mild stress (CMS) followed by an acute stressor (30 min restraint) [g]',\n",
       " 'Cancer biology: Apoptosis of breast tumor cells on day 12 (0 means no apoptosis infiltration and no destruction of implanted tumor cell and 4 means most severe) [index]',\n",
       " 'Immune system: Graft-vs-host reaction, antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone 11.4 B/c [thymidine uptake, cpm]',\n",
       " 'Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells on day 30 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and 4 means most severe destruction) [index]',\n",
       " 'Cancer biology: Mixed lymphocyte reaction (MLR) with BALB/c spleen cells [cpm stimulated/cpm unstimulated]',\n",
       " 'Immune system: T-cell anergy induced by Bacillus Calmette_¾_Gu\\x90©rin tuberculosis vaccine (BCG), delayed type hypersensitivity in footpad increments [mm]',\n",
       " 'Cancer biology: Tumor growth 7 weeks post-implantation [mm3]',\n",
       " 'Cancer biology: Apoptosis of breast tumor cells on day 30 (0 means no apoptosis infiltration and no destruction of implanted tumor cell and 4 means most severe) [index]',\n",
       " 'Cancer biology: Leukocyte infiltration in metastatic breast tumor on day 5 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and 4 means most severe destruction) [index]',\n",
       " 'Immune system: Anti-F antigen (liver protein) titer, experiment 1, log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen [log binding]',\n",
       " 'Cancer biology: Tumor growth and size, 2 weeks post-implantation [mm3]',\n",
       " 'Immune system: Proliferation of T cell clone (A9.4 subclone) with 50 ug/ml KLH experiment 1, 5X10E5 stimulator cells [cpm]',\n",
       " 'Infectious disease, immune system: Respiratory syncytial virus (RSV) response, viral load in whole lung (NS1 gene) 4 days after infection of 5 day old neonates [mean ratio of NS1 to reference NS1]',\n",
       " 'Cancer biology: Tumor growth 3 weeks post-implantation [mm3]',\n",
       " 'Immune system: Proliferation of T cell clone (A9.4 subclone) without 50 ug/ml KLH experiment 1 [cpm]',\n",
       " 'Endocrinology: Serum thyroxine (T4), total serum T4 content [ug/100ml]',\n",
       " 'Endocrinology, metabolism: Serum thyroxine (T4) content (free) [ug/100ml]',\n",
       " 'Immune system: T-cell response, cytotoxic T lymphocytes, 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [units]',\n",
       " 'Immune system: T-cell response, cytotoxic T lymphocytes, Mean 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [units]',\n",
       " 'Immune system: T-cell response, antibody-dependent cell-mediated cytotoxicity, 51Cr release at 5:1 E:T after spleen cells primed and boosted in mixed lymphocyte culture (MLC) in pool of five responders [units]',\n",
       " 'Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 2 [units]',\n",
       " 'Immune system: Proliferation of T cell clone (A9.4 subclone) without 50 ug/ml KLH experiment 2 [cpm]',\n",
       " 'Immune system: Proliferation of T cell clone (A9.4 subclone) with 50 ug/ml KLH experiment 2, 1X10E6 stimulator cells [cpm]',\n",
       " 'Immune system: T-cell response, cytotoxic T lymphocytes, 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units]',\n",
       " 'Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units]',\n",
       " 'Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units]',\n",
       " 'Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 2 [units]',\n",
       " 'Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 10:1 E:T after spleen cells primed and boosted with mixed lymphocyte culture in responder 2 [units]',\n",
       " 'Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 3 [units]',\n",
       " 'Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 3 [units]',\n",
       " 'Cancer biology:Leukocyte infiltration in metastatic breast tumor on day 30 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and 4 means most severe destruction) [index]',\n",
       " 'Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 3 [units]',\n",
       " 'Cancer biology: Growth of syngeneic breast cancer tumors day 50 [mm3]',\n",
       " 'Cancer biology: Growth of syngeneic breast cancer tumors day 45 [mm3]',\n",
       " 'Cancer biology: Growth of syngeneic breast cancer tumors day 40 [mm3]',\n",
       " \"Immune system, infectious disease: S. rectivirgula response (100 ug, three times/week for 2 weeks, one time in third week, (farmer's lung disease), Mice were analyzed 20hrs after the last exposure. Flow cytometry was performed on the BAL cells and B cells\",\n",
       " 'Infectious disease, immune system: Hematocrit 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [proportional packed cell volume of RBCs in whole blood]',\n",
       " 'Blood chemistry, infectious disease, immune system: White blood cell (WBC) count 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [number per ul of whole blood]',\n",
       " 'Infectious disease, immune system: Ratio of number of neutrophil to lymphocyte ratio at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [neutrophil to lymphocyte ratio, whole b',\n",
       " 'Infectious disease, immune system: Leishmania L. mexicana lesion diameter after subcutaneous injection in males (this entry is missing data) [mm]',\n",
       " 'Infectious disease, immune system: Bovine spongioform encephalopathy (prion disease, mouse-adapted scrapie strain ME7), primary transmission incubation period in females [days]',\n",
       " 'Infectious disease, immune system: Burkholderia pseudomallei (strain 1026b, 100 CFU intranasal under isoflurane) survival to 11-days in 12_¾_13 week-old males and females [%]',\n",
       " 'Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells on day 5 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and 4 means most severe destruction) [index]',\n",
       " 'Immunology, infectious disease: Staphloccocus pyogenes (sq injection of 1.0x10x8 CFU) survival index in males and females injected at 10_¾_16 week of age (death before day 3 = 1, death from 3 to 7 = 2, death after day 7 =3) [index]']"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(other_data[3][1][other_data[3][1][\"Category\"] == \"Immune\"].sort_values(\"Strains\", ascending=False)[\"Phenotype\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PhenoID</th>\n",
       "      <th>PhenoID.1</th>\n",
       "      <th>RecordID</th>\n",
       "      <th>Phenotype</th>\n",
       "      <th>Shown_pheno</th>\n",
       "      <th>Category</th>\n",
       "      <th>Category_ID</th>\n",
       "      <th>color</th>\n",
       "      <th>Phenotype_post</th>\n",
       "      <th>Phenotype_pre</th>\n",
       "      <th>Authors</th>\n",
       "      <th>Senior.Author</th>\n",
       "      <th>Abbreviation</th>\n",
       "      <th>Quantitive.trait</th>\n",
       "      <th>Tissues</th>\n",
       "      <th>Diet</th>\n",
       "      <th>Strains</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1472</th>\n",
       "      <td>X1540</td>\n",
       "      <td>1540</td>\n",
       "      <td>10034</td>\n",
       "      <td>Infectious disease, immune system: Salmonella ...</td>\n",
       "      <td>Salmonella typhimurium bacterial strain LT2-Z ...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1473.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Salmonella ...</td>\n",
       "      <td>Infectious disease, immune system: Salmonella ...</td>\n",
       "      <td>Benjamin WH Jr, Turnbough CL Jr, Posey BS, Bri...</td>\n",
       "      <td>Benjamin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1473</th>\n",
       "      <td>X844</td>\n",
       "      <td>844</td>\n",
       "      <td>10035</td>\n",
       "      <td>Infectious disease, immune system: Salmonella ...</td>\n",
       "      <td>Salmonella typhimurium bacterial strain WB500 ...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1474.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Salmonella ...</td>\n",
       "      <td>Infectious disease, immune system: Salmonella ...</td>\n",
       "      <td>Benjamin WH Jr, Turnbough CL Jr, Posey BS, Bri...</td>\n",
       "      <td>Benjamin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1474</th>\n",
       "      <td>X79</td>\n",
       "      <td>79</td>\n",
       "      <td>10036</td>\n",
       "      <td>Infectious disease, immune system: Salmonella ...</td>\n",
       "      <td>Salmonella typhimurium bacterial strain SR-11,...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1475.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Salmonella ...</td>\n",
       "      <td>Infectious disease, immune system: Salmonella ...</td>\n",
       "      <td>Benjamin WH Jr, Turnbough CL Jr, Posey BS, Bri...</td>\n",
       "      <td>Benjamin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1475</th>\n",
       "      <td>X1298</td>\n",
       "      <td>1298</td>\n",
       "      <td>10043</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus-induced mortality in males [3...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1476.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Brownstein DG, Bhatt PN, Gras L, Jacoby RO</td>\n",
       "      <td>Brownstein</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1476</th>\n",
       "      <td>X3912</td>\n",
       "      <td>3912</td>\n",
       "      <td>10044</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus-induced mortality [3 = resist...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1477.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Brownstein DG, Bhatt PN, Gras L, Jacoby RO</td>\n",
       "      <td>Brownstein</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     PhenoID  PhenoID.1  RecordID  \\\n",
       "1472   X1540       1540     10034   \n",
       "1473    X844        844     10035   \n",
       "1474     X79         79     10036   \n",
       "1475   X1298       1298     10043   \n",
       "1476   X3912       3912     10044   \n",
       "\n",
       "                                              Phenotype  \\\n",
       "1472  Infectious disease, immune system: Salmonella ...   \n",
       "1473  Infectious disease, immune system: Salmonella ...   \n",
       "1474  Infectious disease, immune system: Salmonella ...   \n",
       "1475  Infectious disease, immune system: Ectromelia ...   \n",
       "1476  Infectious disease, immune system: Ectromelia ...   \n",
       "\n",
       "                                            Shown_pheno Category  Category_ID  \\\n",
       "1472  Salmonella typhimurium bacterial strain LT2-Z ...   Immune       1473.0   \n",
       "1473  Salmonella typhimurium bacterial strain WB500 ...   Immune       1474.0   \n",
       "1474  Salmonella typhimurium bacterial strain SR-11,...   Immune       1475.0   \n",
       "1475  Ectromelia virus-induced mortality in males [3...   Immune       1476.0   \n",
       "1476  Ectromelia virus-induced mortality [3 = resist...   Immune       1477.0   \n",
       "\n",
       "      color                                     Phenotype_post  \\\n",
       "1472    5.0  Infectious disease, immune system: Salmonella ...   \n",
       "1473    5.0  Infectious disease, immune system: Salmonella ...   \n",
       "1474    5.0  Infectious disease, immune system: Salmonella ...   \n",
       "1475    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "1476    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "\n",
       "                                          Phenotype_pre  \\\n",
       "1472  Infectious disease, immune system: Salmonella ...   \n",
       "1473  Infectious disease, immune system: Salmonella ...   \n",
       "1474  Infectious disease, immune system: Salmonella ...   \n",
       "1475  Infectious disease, immune system: Ectromelia ...   \n",
       "1476  Infectious disease, immune system: Ectromelia ...   \n",
       "\n",
       "                                                Authors Senior.Author  \\\n",
       "1472  Benjamin WH Jr, Turnbough CL Jr, Posey BS, Bri...      Benjamin   \n",
       "1473  Benjamin WH Jr, Turnbough CL Jr, Posey BS, Bri...      Benjamin   \n",
       "1474  Benjamin WH Jr, Turnbough CL Jr, Posey BS, Bri...      Benjamin   \n",
       "1475         Brownstein DG, Bhatt PN, Gras L, Jacoby RO    Brownstein   \n",
       "1476         Brownstein DG, Bhatt PN, Gras L, Jacoby RO    Brownstein   \n",
       "\n",
       "     Abbreviation Quantitive.trait Tissues Diet  Strains  \n",
       "1472          NaN              Yes     NaN  NaN       20  \n",
       "1473          NaN              Yes     NaN  NaN       20  \n",
       "1474          NaN              Yes     NaN  NaN       19  \n",
       "1475          NaN              Yes     NaN  NaN       28  \n",
       "1476          NaN              Yes     NaN  NaN       28  "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Immune.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PhenoID</th>\n",
       "      <th>PhenoID.1</th>\n",
       "      <th>RecordID</th>\n",
       "      <th>Phenotype</th>\n",
       "      <th>Shown_pheno</th>\n",
       "      <th>Category</th>\n",
       "      <th>Category_ID</th>\n",
       "      <th>color</th>\n",
       "      <th>Phenotype_post</th>\n",
       "      <th>Phenotype_pre</th>\n",
       "      <th>Authors</th>\n",
       "      <th>Senior.Author</th>\n",
       "      <th>Abbreviation</th>\n",
       "      <th>Quantitive.trait</th>\n",
       "      <th>Tissues</th>\n",
       "      <th>Diet</th>\n",
       "      <th>Strains</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1600</th>\n",
       "      <td>X657</td>\n",
       "      <td>657</td>\n",
       "      <td>10865</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>H5N1 influenza A virus mortality rate 30 days ...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1601.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>Boon ACM, deBeauchamp J, Hollmann A, Luke J, K...</td>\n",
       "      <td>Webby</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1601</th>\n",
       "      <td>X893</td>\n",
       "      <td>893</td>\n",
       "      <td>10866</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>H5N1 influenza A virus survival time (10^4 EID...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1602.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>Boon ACM, deBeauchamp J, Hollmann A, Luke J, K...</td>\n",
       "      <td>Webby</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1819</th>\n",
       "      <td>X1687</td>\n",
       "      <td>1687</td>\n",
       "      <td>16321</td>\n",
       "      <td>Immune system: ELISA-3x, IgG class antibody bi...</td>\n",
       "      <td>ELISA-3x, IgG class antibody binding to TSHR A...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1820.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Immune system: ELISA-3x, IgG class antibody bi...</td>\n",
       "      <td>Immune system: ELISA-3x, IgG class antibody bi...</td>\n",
       "      <td>S.M. McLachlan, H. Aliesky, R.W. Williams, B. ...</td>\n",
       "      <td>McLachlan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>68</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1815</th>\n",
       "      <td>X3828</td>\n",
       "      <td>3828</td>\n",
       "      <td>16314</td>\n",
       "      <td>Immune system, endocrinology: serum inhibition...</td>\n",
       "      <td>serum inhibition of TSH binding to the TSHR be...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1816.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Immune system, endocrinology: serum inhibition...</td>\n",
       "      <td>Immune system: TBI-0x, pre-immunization serum ...</td>\n",
       "      <td>S.M. McLachlan, H. Aliesky, R.W. Williams, B. ...</td>\n",
       "      <td>McLachlan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>68</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1817</th>\n",
       "      <td>X74</td>\n",
       "      <td>74</td>\n",
       "      <td>16316</td>\n",
       "      <td>Immune system, endocrinology: Serum inhibition...</td>\n",
       "      <td>Serum inhibition of TSH binding to the TSHR 4 ...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1818.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Immune system, endocrinology: Serum inhibition...</td>\n",
       "      <td>Immune system, endocrinology: Serum inhibition...</td>\n",
       "      <td>McLachlan SM, Aliesky H, Banuelos B, Magana J,...</td>\n",
       "      <td>McLachlan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>68</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1816</th>\n",
       "      <td>X98</td>\n",
       "      <td>98</td>\n",
       "      <td>16315</td>\n",
       "      <td>Immune system, endocrine system: TBI-2x, serum...</td>\n",
       "      <td>TBI-2x, serum inhibition of TSH binding to the...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1817.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Immune system, endocrine system: TBI-2x, serum...</td>\n",
       "      <td>Immune system, endocrine system: TBI-2x, serum...</td>\n",
       "      <td>McLachlan, H. Aliesky, R.W. Williams, B. Rapoport</td>\n",
       "      <td>McLachlan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1818</th>\n",
       "      <td>X2102</td>\n",
       "      <td>2102</td>\n",
       "      <td>16320</td>\n",
       "      <td>Immune system: ELISA-2x, IgG class antibody bi...</td>\n",
       "      <td>ELISA-2x, IgG class antibody binding to TSHR A...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1819.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Immune system: ELISA-2x, IgG class antibody bi...</td>\n",
       "      <td>Immune system: ELISA-2x, IgG class antibody bi...</td>\n",
       "      <td>S.M. McLachlan, H. Aliesky, R.W. Williams, B. ...</td>\n",
       "      <td>McLachlan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1782</th>\n",
       "      <td>X3655</td>\n",
       "      <td>3655</td>\n",
       "      <td>15133</td>\n",
       "      <td>Infectious disease, immune system: Malaria inf...</td>\n",
       "      <td>Malaria infection lethality, Plasmodium yoelii...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1783.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Malaria inf...</td>\n",
       "      <td>Infectious disease, immune system: Malaria inf...</td>\n",
       "      <td>Mogil RJ, Green D, Williams RW, Lu L, and coll...</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>63</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1638</th>\n",
       "      <td>X387</td>\n",
       "      <td>387</td>\n",
       "      <td>12683</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus mortality score (combined dat...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1639.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Rice AD, Moyer RW, Williams RW</td>\n",
       "      <td>Rice</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>61</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1851</th>\n",
       "      <td>X4233</td>\n",
       "      <td>4233</td>\n",
       "      <td>18440</td>\n",
       "      <td>Infectious disease, immune system: Malaria sus...</td>\n",
       "      <td>Malaria susceptibility, murine Plasmodium yoel...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1852.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Malaria sus...</td>\n",
       "      <td>Infectious disease, immune system: Malaria inf...</td>\n",
       "      <td>Mogil RJ, Lu L, Green DR, Williams RW (contact...</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>60</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1682</th>\n",
       "      <td>X593</td>\n",
       "      <td>593</td>\n",
       "      <td>13009</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1683.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1681</th>\n",
       "      <td>X1868</td>\n",
       "      <td>1868</td>\n",
       "      <td>13008</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1682.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1685</th>\n",
       "      <td>X2558</td>\n",
       "      <td>2558</td>\n",
       "      <td>13012</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1686.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1683</th>\n",
       "      <td>X544</td>\n",
       "      <td>544</td>\n",
       "      <td>13010</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1684.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1684</th>\n",
       "      <td>X1481</td>\n",
       "      <td>1481</td>\n",
       "      <td>13011</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1685.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1679</th>\n",
       "      <td>X2637</td>\n",
       "      <td>2637</td>\n",
       "      <td>13006</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1680.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1680</th>\n",
       "      <td>X2468</td>\n",
       "      <td>2468</td>\n",
       "      <td>13007</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1681.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1676</th>\n",
       "      <td>X1071</td>\n",
       "      <td>1071</td>\n",
       "      <td>13003</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), per...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1677.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1678</th>\n",
       "      <td>X1832</td>\n",
       "      <td>1832</td>\n",
       "      <td>13005</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1679.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1677</th>\n",
       "      <td>X1618</td>\n",
       "      <td>1618</td>\n",
       "      <td>13004</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), per...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1678.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1687</th>\n",
       "      <td>X1586</td>\n",
       "      <td>1586</td>\n",
       "      <td>13014</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1688.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1675</th>\n",
       "      <td>X511</td>\n",
       "      <td>511</td>\n",
       "      <td>13002</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), per...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1676.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1674</th>\n",
       "      <td>X217</td>\n",
       "      <td>217</td>\n",
       "      <td>13001</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), per...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1675.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1673</th>\n",
       "      <td>X1797</td>\n",
       "      <td>1797</td>\n",
       "      <td>13000</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), per...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1674.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1672</th>\n",
       "      <td>X419</td>\n",
       "      <td>419</td>\n",
       "      <td>12996</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), mea...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1673.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1688</th>\n",
       "      <td>X2030</td>\n",
       "      <td>2030</td>\n",
       "      <td>13015</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1689.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1689</th>\n",
       "      <td>X1288</td>\n",
       "      <td>1288</td>\n",
       "      <td>13016</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1690.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1690</th>\n",
       "      <td>X1573</td>\n",
       "      <td>1573</td>\n",
       "      <td>13017</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1691.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1686</th>\n",
       "      <td>X2275</td>\n",
       "      <td>2275</td>\n",
       "      <td>13013</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1687.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1666</th>\n",
       "      <td>X670</td>\n",
       "      <td>670</td>\n",
       "      <td>12969</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Malaria lethality, Plasmodium yoelii (PY17X su...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1667.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Mogil, RJ and Williams, R</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>54</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1665</th>\n",
       "      <td>X3733</td>\n",
       "      <td>3733</td>\n",
       "      <td>12968</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Malaria lethality, Plasmodium yoelii (PY17X su...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1666.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Mogil, RJ and Williams, R</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>53</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1667</th>\n",
       "      <td>X216</td>\n",
       "      <td>216</td>\n",
       "      <td>12971</td>\n",
       "      <td>Infectious disease, immune system: TNFa cytoki...</td>\n",
       "      <td>TNFa cytokine expression level two days after ...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1668.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: TNFa cytoki...</td>\n",
       "      <td>Infectious disease, immune system: TNFa cytoki...</td>\n",
       "      <td>Boon AC, Williams RW, Sinasac DS, Webby RJ</td>\n",
       "      <td>Webby</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>47</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1668</th>\n",
       "      <td>X1144</td>\n",
       "      <td>1144</td>\n",
       "      <td>12972</td>\n",
       "      <td>Infectious disease, immune system: MCP1 cytoki...</td>\n",
       "      <td>MCP1 cytokine expression level two days after ...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1669.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: MCP1 cytoki...</td>\n",
       "      <td>Infectious disease, immune system: MCP1 cytoki...</td>\n",
       "      <td>Boon AC, Williams RW, Sinasac DS, Webby RJ</td>\n",
       "      <td>Webby</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>47</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1669</th>\n",
       "      <td>X194</td>\n",
       "      <td>194</td>\n",
       "      <td>12973</td>\n",
       "      <td>Infectious disease, immune system: Interferon ...</td>\n",
       "      <td>Interferon alpha (IFNa) cytokine expression le...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1670.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Interferon ...</td>\n",
       "      <td>Infectious disease, immune system: Interferon ...</td>\n",
       "      <td>Boon AC, Williams RW, Sinasac DS, Webby RJ</td>\n",
       "      <td>Webby</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>46</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1629</th>\n",
       "      <td>X1139</td>\n",
       "      <td>1139</td>\n",
       "      <td>12674</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus measure of severity of diseas...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1630.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Rice AD, Moyer RW</td>\n",
       "      <td>Rice</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>45</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1627</th>\n",
       "      <td>X521</td>\n",
       "      <td>521</td>\n",
       "      <td>12672</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus survival over two weeks after...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1628.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Rice AD, Moyer RW</td>\n",
       "      <td>Rice</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>45</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1628</th>\n",
       "      <td>X4331</td>\n",
       "      <td>4331</td>\n",
       "      <td>12673</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus formation of secondary dermal...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1629.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Rice AD, Moyer RW</td>\n",
       "      <td>Rice</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>45</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1671</th>\n",
       "      <td>X2266</td>\n",
       "      <td>2266</td>\n",
       "      <td>12995</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Malaria lethality, Plasmodium yoelii (PY17XL s...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1672.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Mogil RJ and Williams R</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>45</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1630</th>\n",
       "      <td>X2346</td>\n",
       "      <td>2346</td>\n",
       "      <td>12675</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus measure of disease onset meas...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1631.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Rice AD, Moyer RW</td>\n",
       "      <td>Rice</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>45</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1802</th>\n",
       "      <td>X4135</td>\n",
       "      <td>4135</td>\n",
       "      <td>15964</td>\n",
       "      <td>Infectious disease, immune system: Malaria sus...</td>\n",
       "      <td>Malaria susceptibility, murine Plasmodium yoel...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1803.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Malaria sus...</td>\n",
       "      <td>Infectious disease, immune system: Rona J Mogi...</td>\n",
       "      <td>Mogil RJ, Lu L, Green D, Williams RW</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>43</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1670</th>\n",
       "      <td>X4722</td>\n",
       "      <td>4722</td>\n",
       "      <td>12994</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Malaria lethality, Plasmodium yoelii (PY17XL s...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1671.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Mogil RJ and Williams R</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>43</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1797</th>\n",
       "      <td>X3561</td>\n",
       "      <td>3561</td>\n",
       "      <td>15568</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Kramer RM, Lamkin T, and colleagues, TAFI13</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1798.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Kramer RM; Lamkin TJ</td>\n",
       "      <td>Kramer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>41</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1796</th>\n",
       "      <td>X4530</td>\n",
       "      <td>4530</td>\n",
       "      <td>15566</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Kramer RM, Lamkin T, and colleagues TAFI12</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1797.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Kramer RM, Lamkin TJ</td>\n",
       "      <td>Kramer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>40</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1792</th>\n",
       "      <td>X1572</td>\n",
       "      <td>1572</td>\n",
       "      <td>15562</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Kramer RM, Lamkin T, and colleagues TAFI8</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1793.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Kramer RM, Lamkin TJ</td>\n",
       "      <td>Kramer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1793</th>\n",
       "      <td>X1650</td>\n",
       "      <td>1650</td>\n",
       "      <td>15563</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Kramer RM, Lamkin T, and colleagues TAFI9</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1794.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Kramer RM, Lamkin TJ</td>\n",
       "      <td>Kramer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1623</th>\n",
       "      <td>X884</td>\n",
       "      <td>884</td>\n",
       "      <td>12668</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus formation of secondary dermal...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1624.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Rice AD, Moyer RW</td>\n",
       "      <td>Rice</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>38</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1624</th>\n",
       "      <td>X1274</td>\n",
       "      <td>1274</td>\n",
       "      <td>12669</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus euthanasia scale over two wee...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1625.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Rice AD, Moyer RW</td>\n",
       "      <td>Rice</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>38</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1622</th>\n",
       "      <td>X587</td>\n",
       "      <td>587</td>\n",
       "      <td>12667</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus survival over two weeks after...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1623.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Rice AD, Moyer RW</td>\n",
       "      <td>Rice</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>38</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1794</th>\n",
       "      <td>X782</td>\n",
       "      <td>782</td>\n",
       "      <td>15564</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Kramer RM, Lamkin T, and colleagues TAFI10</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1795.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Infectious disease, immune system: Kramer RM, ...</td>\n",
       "      <td>Kramer RM, Lamkin TJ</td>\n",
       "      <td>Kramer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>38</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1626</th>\n",
       "      <td>X378</td>\n",
       "      <td>378</td>\n",
       "      <td>12671</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Ectromelia virus measure of severity of diseas...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1627.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Infectious disease, immune system: Ectromelia ...</td>\n",
       "      <td>Rice AD, Moyer RW</td>\n",
       "      <td>Rice</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>38</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     PhenoID  PhenoID.1  RecordID  \\\n",
       "1600    X657        657     10865   \n",
       "1601    X893        893     10866   \n",
       "1819   X1687       1687     16321   \n",
       "1815   X3828       3828     16314   \n",
       "1817     X74         74     16316   \n",
       "1816     X98         98     16315   \n",
       "1818   X2102       2102     16320   \n",
       "1782   X3655       3655     15133   \n",
       "1638    X387        387     12683   \n",
       "1851   X4233       4233     18440   \n",
       "1682    X593        593     13009   \n",
       "1681   X1868       1868     13008   \n",
       "1685   X2558       2558     13012   \n",
       "1683    X544        544     13010   \n",
       "1684   X1481       1481     13011   \n",
       "1679   X2637       2637     13006   \n",
       "1680   X2468       2468     13007   \n",
       "1676   X1071       1071     13003   \n",
       "1678   X1832       1832     13005   \n",
       "1677   X1618       1618     13004   \n",
       "1687   X1586       1586     13014   \n",
       "1675    X511        511     13002   \n",
       "1674    X217        217     13001   \n",
       "1673   X1797       1797     13000   \n",
       "1672    X419        419     12996   \n",
       "1688   X2030       2030     13015   \n",
       "1689   X1288       1288     13016   \n",
       "1690   X1573       1573     13017   \n",
       "1686   X2275       2275     13013   \n",
       "1666    X670        670     12969   \n",
       "1665   X3733       3733     12968   \n",
       "1667    X216        216     12971   \n",
       "1668   X1144       1144     12972   \n",
       "1669    X194        194     12973   \n",
       "1629   X1139       1139     12674   \n",
       "1627    X521        521     12672   \n",
       "1628   X4331       4331     12673   \n",
       "1671   X2266       2266     12995   \n",
       "1630   X2346       2346     12675   \n",
       "1802   X4135       4135     15964   \n",
       "1670   X4722       4722     12994   \n",
       "1797   X3561       3561     15568   \n",
       "1796   X4530       4530     15566   \n",
       "1792   X1572       1572     15562   \n",
       "1793   X1650       1650     15563   \n",
       "1623    X884        884     12668   \n",
       "1624   X1274       1274     12669   \n",
       "1622    X587        587     12667   \n",
       "1794    X782        782     15564   \n",
       "1626    X378        378     12671   \n",
       "\n",
       "                                              Phenotype  \\\n",
       "1600  Infectious disease, immune system: H5N1 influe...   \n",
       "1601  Infectious disease, immune system: H5N1 influe...   \n",
       "1819  Immune system: ELISA-3x, IgG class antibody bi...   \n",
       "1815  Immune system, endocrinology: serum inhibition...   \n",
       "1817  Immune system, endocrinology: Serum inhibition...   \n",
       "1816  Immune system, endocrine system: TBI-2x, serum...   \n",
       "1818  Immune system: ELISA-2x, IgG class antibody bi...   \n",
       "1782  Infectious disease, immune system: Malaria inf...   \n",
       "1638  Infectious disease, immune system: Ectromelia ...   \n",
       "1851  Infectious disease, immune system: Malaria sus...   \n",
       "1682  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1681  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1685  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1683  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1684  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1679  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1680  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1676  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1678  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1677  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1687  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1675  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1674  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1673  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1672  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1688  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1689  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1690  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1686  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1666  Infectious disease, immune function: Malaria l...   \n",
       "1665  Infectious disease, immune function: Malaria l...   \n",
       "1667  Infectious disease, immune system: TNFa cytoki...   \n",
       "1668  Infectious disease, immune system: MCP1 cytoki...   \n",
       "1669  Infectious disease, immune system: Interferon ...   \n",
       "1629  Infectious disease, immune system: Ectromelia ...   \n",
       "1627  Infectious disease, immune system: Ectromelia ...   \n",
       "1628  Infectious disease, immune system: Ectromelia ...   \n",
       "1671  Infectious disease, immune function: Malaria l...   \n",
       "1630  Infectious disease, immune system: Ectromelia ...   \n",
       "1802  Infectious disease, immune system: Malaria sus...   \n",
       "1670  Infectious disease, immune function: Malaria l...   \n",
       "1797  Infectious disease, immune system: Kramer RM, ...   \n",
       "1796  Infectious disease, immune system: Kramer RM, ...   \n",
       "1792  Infectious disease, immune system: Kramer RM, ...   \n",
       "1793  Infectious disease, immune system: Kramer RM, ...   \n",
       "1623  Infectious disease, immune system: Ectromelia ...   \n",
       "1624  Infectious disease, immune system: Ectromelia ...   \n",
       "1622  Infectious disease, immune system: Ectromelia ...   \n",
       "1794  Infectious disease, immune system: Kramer RM, ...   \n",
       "1626  Infectious disease, immune system: Ectromelia ...   \n",
       "\n",
       "                                            Shown_pheno Category  Category_ID  \\\n",
       "1600  H5N1 influenza A virus mortality rate 30 days ...   Immune       1601.0   \n",
       "1601  H5N1 influenza A virus survival time (10^4 EID...   Immune       1602.0   \n",
       "1819  ELISA-3x, IgG class antibody binding to TSHR A...   Immune       1820.0   \n",
       "1815  serum inhibition of TSH binding to the TSHR be...   Immune       1816.0   \n",
       "1817  Serum inhibition of TSH binding to the TSHR 4 ...   Immune       1818.0   \n",
       "1816  TBI-2x, serum inhibition of TSH binding to the...   Immune       1817.0   \n",
       "1818  ELISA-2x, IgG class antibody binding to TSHR A...   Immune       1819.0   \n",
       "1782  Malaria infection lethality, Plasmodium yoelii...   Immune       1783.0   \n",
       "1638  Ectromelia virus mortality score (combined dat...   Immune       1639.0   \n",
       "1851  Malaria susceptibility, murine Plasmodium yoel...   Immune       1852.0   \n",
       "1682  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1683.0   \n",
       "1681  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1682.0   \n",
       "1685  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1686.0   \n",
       "1683  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1684.0   \n",
       "1684  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1685.0   \n",
       "1679  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1680.0   \n",
       "1680  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1681.0   \n",
       "1676  H1N1 (PR8) influenza A virus (2x10E3 FFU), per...   Immune       1677.0   \n",
       "1678  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1679.0   \n",
       "1677  H1N1 (PR8) influenza A virus (2x10E3 FFU), per...   Immune       1678.0   \n",
       "1687  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1688.0   \n",
       "1675  H1N1 (PR8) influenza A virus (2x10E3 FFU), per...   Immune       1676.0   \n",
       "1674  H1N1 (PR8) influenza A virus (2x10E3 FFU), per...   Immune       1675.0   \n",
       "1673  H1N1 (PR8) influenza A virus (2x10E3 FFU), per...   Immune       1674.0   \n",
       "1672  H1N1 (PR8) influenza A virus (2x10E3 FFU), mea...   Immune       1673.0   \n",
       "1688  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1689.0   \n",
       "1689  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1690.0   \n",
       "1690  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1691.0   \n",
       "1686  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1687.0   \n",
       "1666  Malaria lethality, Plasmodium yoelii (PY17X su...   Immune       1667.0   \n",
       "1665  Malaria lethality, Plasmodium yoelii (PY17X su...   Immune       1666.0   \n",
       "1667  TNFa cytokine expression level two days after ...   Immune       1668.0   \n",
       "1668  MCP1 cytokine expression level two days after ...   Immune       1669.0   \n",
       "1669  Interferon alpha (IFNa) cytokine expression le...   Immune       1670.0   \n",
       "1629  Ectromelia virus measure of severity of diseas...   Immune       1630.0   \n",
       "1627  Ectromelia virus survival over two weeks after...   Immune       1628.0   \n",
       "1628  Ectromelia virus formation of secondary dermal...   Immune       1629.0   \n",
       "1671  Malaria lethality, Plasmodium yoelii (PY17XL s...   Immune       1672.0   \n",
       "1630  Ectromelia virus measure of disease onset meas...   Immune       1631.0   \n",
       "1802  Malaria susceptibility, murine Plasmodium yoel...   Immune       1803.0   \n",
       "1670  Malaria lethality, Plasmodium yoelii (PY17XL s...   Immune       1671.0   \n",
       "1797        Kramer RM, Lamkin T, and colleagues, TAFI13   Immune       1798.0   \n",
       "1796         Kramer RM, Lamkin T, and colleagues TAFI12   Immune       1797.0   \n",
       "1792          Kramer RM, Lamkin T, and colleagues TAFI8   Immune       1793.0   \n",
       "1793          Kramer RM, Lamkin T, and colleagues TAFI9   Immune       1794.0   \n",
       "1623  Ectromelia virus formation of secondary dermal...   Immune       1624.0   \n",
       "1624  Ectromelia virus euthanasia scale over two wee...   Immune       1625.0   \n",
       "1622  Ectromelia virus survival over two weeks after...   Immune       1623.0   \n",
       "1794         Kramer RM, Lamkin T, and colleagues TAFI10   Immune       1795.0   \n",
       "1626  Ectromelia virus measure of severity of diseas...   Immune       1627.0   \n",
       "\n",
       "      color                                     Phenotype_post  \\\n",
       "1600    5.0  Infectious disease, immune system: H5N1 influe...   \n",
       "1601    5.0  Infectious disease, immune system: H5N1 influe...   \n",
       "1819    5.0  Immune system: ELISA-3x, IgG class antibody bi...   \n",
       "1815    5.0  Immune system, endocrinology: serum inhibition...   \n",
       "1817    5.0  Immune system, endocrinology: Serum inhibition...   \n",
       "1816    5.0  Immune system, endocrine system: TBI-2x, serum...   \n",
       "1818    5.0  Immune system: ELISA-2x, IgG class antibody bi...   \n",
       "1782    5.0  Infectious disease, immune system: Malaria inf...   \n",
       "1638    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "1851    5.0  Infectious disease, immune system: Malaria sus...   \n",
       "1682    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1681    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1685    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1683    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1684    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1679    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1680    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1676    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1678    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1677    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1687    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1675    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1674    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1673    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1672    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1688    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1689    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1690    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1686    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1666    5.0  Infectious disease, immune function: Malaria l...   \n",
       "1665    5.0  Infectious disease, immune function: Malaria l...   \n",
       "1667    5.0  Infectious disease, immune system: TNFa cytoki...   \n",
       "1668    5.0  Infectious disease, immune system: MCP1 cytoki...   \n",
       "1669    5.0  Infectious disease, immune system: Interferon ...   \n",
       "1629    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "1627    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "1628    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "1671    5.0  Infectious disease, immune function: Malaria l...   \n",
       "1630    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "1802    5.0  Infectious disease, immune system: Malaria sus...   \n",
       "1670    5.0  Infectious disease, immune function: Malaria l...   \n",
       "1797    5.0  Infectious disease, immune system: Kramer RM, ...   \n",
       "1796    5.0  Infectious disease, immune system: Kramer RM, ...   \n",
       "1792    5.0  Infectious disease, immune system: Kramer RM, ...   \n",
       "1793    5.0  Infectious disease, immune system: Kramer RM, ...   \n",
       "1623    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "1624    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "1622    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "1794    5.0  Infectious disease, immune system: Kramer RM, ...   \n",
       "1626    5.0  Infectious disease, immune system: Ectromelia ...   \n",
       "\n",
       "                                          Phenotype_pre  \\\n",
       "1600  Infectious disease, immune system: H5N1 influe...   \n",
       "1601  Infectious disease, immune system: H5N1 influe...   \n",
       "1819  Immune system: ELISA-3x, IgG class antibody bi...   \n",
       "1815  Immune system: TBI-0x, pre-immunization serum ...   \n",
       "1817  Immune system, endocrinology: Serum inhibition...   \n",
       "1816  Immune system, endocrine system: TBI-2x, serum...   \n",
       "1818  Immune system: ELISA-2x, IgG class antibody bi...   \n",
       "1782  Infectious disease, immune system: Malaria inf...   \n",
       "1638  Infectious disease, immune system: Ectromelia ...   \n",
       "1851  Infectious disease, immune system: Malaria inf...   \n",
       "1682  Infectious disease, immune function: Schughart...   \n",
       "1681  Infectious disease, immune function: Schughart...   \n",
       "1685  Infectious disease, immune function: Schughart...   \n",
       "1683  Infectious disease, immune function: Schughart...   \n",
       "1684  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1679  Infectious disease, immune function: Schughart...   \n",
       "1680  Infectious disease, immune function: Schughart...   \n",
       "1676  Infectious disease, immune function: Schughart...   \n",
       "1678  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1677  Infectious disease, immune function: Schughart...   \n",
       "1687  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1675  Infectious disease, immune function: Schughart...   \n",
       "1674  Infectious disease, immune function: Schughart...   \n",
       "1673  Infectious disease, immune function: Schughart...   \n",
       "1672  Infectious disease, immune function: Schughart...   \n",
       "1688  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1689  Infectious disease, immune function: Schughart...   \n",
       "1690  Infectious disease, immune function: Schughart...   \n",
       "1686  Infectious disease, immune function: Schughart...   \n",
       "1666  Infectious disease, immune function: Malaria l...   \n",
       "1665  Infectious disease, immune function: Malaria l...   \n",
       "1667  Infectious disease, immune system: TNFa cytoki...   \n",
       "1668  Infectious disease, immune system: MCP1 cytoki...   \n",
       "1669  Infectious disease, immune system: Interferon ...   \n",
       "1629  Infectious disease, immune system: Ectromelia ...   \n",
       "1627  Infectious disease, immune system: Ectromelia ...   \n",
       "1628  Infectious disease, immune system: Ectromelia ...   \n",
       "1671  Infectious disease, immune function: Malaria l...   \n",
       "1630  Infectious disease, immune system: Ectromelia ...   \n",
       "1802  Infectious disease, immune system: Rona J Mogi...   \n",
       "1670  Infectious disease, immune function: Malaria l...   \n",
       "1797  Infectious disease, immune system: Kramer RM, ...   \n",
       "1796  Infectious disease, immune system: Kramer RM, ...   \n",
       "1792  Infectious disease, immune system: Kramer RM, ...   \n",
       "1793  Infectious disease, immune system: Kramer RM, ...   \n",
       "1623  Infectious disease, immune system: Ectromelia ...   \n",
       "1624  Infectious disease, immune system: Ectromelia ...   \n",
       "1622  Infectious disease, immune system: Ectromelia ...   \n",
       "1794  Infectious disease, immune system: Kramer RM, ...   \n",
       "1626  Infectious disease, immune system: Ectromelia ...   \n",
       "\n",
       "                                                Authors Senior.Author  \\\n",
       "1600  Boon ACM, deBeauchamp J, Hollmann A, Luke J, K...         Webby   \n",
       "1601  Boon ACM, deBeauchamp J, Hollmann A, Luke J, K...         Webby   \n",
       "1819  S.M. McLachlan, H. Aliesky, R.W. Williams, B. ...     McLachlan   \n",
       "1815  S.M. McLachlan, H. Aliesky, R.W. Williams, B. ...     McLachlan   \n",
       "1817  McLachlan SM, Aliesky H, Banuelos B, Magana J,...     McLachlan   \n",
       "1816  McLachlan, H. Aliesky, R.W. Williams, B. Rapoport     McLachlan   \n",
       "1818  S.M. McLachlan, H. Aliesky, R.W. Williams, B. ...     McLachlan   \n",
       "1782  Mogil RJ, Green D, Williams RW, Lu L, and coll...         Mogil   \n",
       "1638                     Rice AD, Moyer RW, Williams RW          Rice   \n",
       "1851  Mogil RJ, Lu L, Green DR, Williams RW (contact...         Mogil   \n",
       "1682                                        Schughart K     Schughart   \n",
       "1681                                        Schughart K     Schughart   \n",
       "1685                                        Schughart K     Schughart   \n",
       "1683                                        Schughart K     Schughart   \n",
       "1684  Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...     Schughart   \n",
       "1679                                        Schughart K     Schughart   \n",
       "1680                                        Schughart K     Schughart   \n",
       "1676                                        Schughart K     Schughart   \n",
       "1678  Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...     Schughart   \n",
       "1677                                        Schughart K     Schughart   \n",
       "1687  Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...     Schughart   \n",
       "1675                                        Schughart K     Schughart   \n",
       "1674                                        Schughart K     Schughart   \n",
       "1673                                        Schughart K     Schughart   \n",
       "1672                                        Schughart K     Schughart   \n",
       "1688  Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...     Schughart   \n",
       "1689                                        Schughart K     Schughart   \n",
       "1690                                        Schughart K     Schughart   \n",
       "1686                                        Schughart K     Schughart   \n",
       "1666                          Mogil, RJ and Williams, R         Mogil   \n",
       "1665                          Mogil, RJ and Williams, R         Mogil   \n",
       "1667         Boon AC, Williams RW, Sinasac DS, Webby RJ         Webby   \n",
       "1668         Boon AC, Williams RW, Sinasac DS, Webby RJ         Webby   \n",
       "1669         Boon AC, Williams RW, Sinasac DS, Webby RJ         Webby   \n",
       "1629                                  Rice AD, Moyer RW          Rice   \n",
       "1627                                  Rice AD, Moyer RW          Rice   \n",
       "1628                                  Rice AD, Moyer RW          Rice   \n",
       "1671                            Mogil RJ and Williams R         Mogil   \n",
       "1630                                  Rice AD, Moyer RW          Rice   \n",
       "1802               Mogil RJ, Lu L, Green D, Williams RW         Mogil   \n",
       "1670                            Mogil RJ and Williams R         Mogil   \n",
       "1797                               Kramer RM; Lamkin TJ        Kramer   \n",
       "1796                               Kramer RM, Lamkin TJ        Kramer   \n",
       "1792                               Kramer RM, Lamkin TJ        Kramer   \n",
       "1793                               Kramer RM, Lamkin TJ        Kramer   \n",
       "1623                                  Rice AD, Moyer RW          Rice   \n",
       "1624                                  Rice AD, Moyer RW          Rice   \n",
       "1622                                  Rice AD, Moyer RW          Rice   \n",
       "1794                               Kramer RM, Lamkin TJ        Kramer   \n",
       "1626                                  Rice AD, Moyer RW          Rice   \n",
       "\n",
       "     Abbreviation Quantitive.trait Tissues Diet  Strains  \n",
       "1600          NaN              Yes     NaN  NaN       69  \n",
       "1601          NaN              Yes     NaN  NaN       69  \n",
       "1819          NaN              Yes     NaN  NaN       68  \n",
       "1815          NaN              Yes     NaN  NaN       68  \n",
       "1817          NaN              Yes     NaN  NaN       68  \n",
       "1816          NaN              Yes     NaN  NaN       65  \n",
       "1818          NaN              Yes     NaN  NaN       65  \n",
       "1782          NaN              Yes     NaN  NaN       63  \n",
       "1638          NaN              Yes     NaN  NaN       61  \n",
       "1851          NaN              Yes     NaN  NaN       60  \n",
       "1682          NaN              Yes     NaN  NaN       56  \n",
       "1681          NaN              Yes     NaN  NaN       56  \n",
       "1685          NaN              Yes     NaN  NaN       56  \n",
       "1683          NaN              Yes     NaN  NaN       56  \n",
       "1684          NaN              Yes     NaN  NaN       56  \n",
       "1679          NaN              Yes     NaN  NaN       56  \n",
       "1680          NaN              Yes     NaN  NaN       56  \n",
       "1676          NaN              Yes     NaN  NaN       56  \n",
       "1678          NaN              Yes     NaN  NaN       56  \n",
       "1677          NaN              Yes     NaN  NaN       56  \n",
       "1687          NaN              Yes     NaN  NaN       56  \n",
       "1675          NaN              Yes     NaN  NaN       56  \n",
       "1674          NaN              Yes     NaN  NaN       56  \n",
       "1673          NaN              Yes     NaN  NaN       56  \n",
       "1672          NaN              Yes     NaN  NaN       56  \n",
       "1688          NaN              Yes     NaN  NaN       56  \n",
       "1689          NaN              Yes     NaN  NaN       56  \n",
       "1690          NaN              Yes     NaN  NaN       56  \n",
       "1686          NaN              Yes     NaN  NaN       56  \n",
       "1666          NaN              Yes     NaN  NaN       54  \n",
       "1665          NaN              Yes     NaN  NaN       53  \n",
       "1667          NaN              Yes     NaN  NaN       47  \n",
       "1668          NaN              Yes     NaN  NaN       47  \n",
       "1669          NaN              Yes     NaN  NaN       46  \n",
       "1629          NaN              Yes     NaN  NaN       45  \n",
       "1627          NaN              Yes     NaN  NaN       45  \n",
       "1628          NaN              Yes     NaN  NaN       45  \n",
       "1671          NaN              Yes     NaN  NaN       45  \n",
       "1630          NaN              Yes     NaN  NaN       45  \n",
       "1802          NaN              Yes     NaN  NaN       43  \n",
       "1670          NaN              Yes     NaN  NaN       43  \n",
       "1797          NaN              Yes     NaN  NaN       41  \n",
       "1796          NaN              Yes     NaN  NaN       40  \n",
       "1792          NaN              Yes     NaN  NaN       39  \n",
       "1793          NaN              Yes     NaN  NaN       39  \n",
       "1623          NaN              Yes     NaN  NaN       38  \n",
       "1624          NaN              Yes     NaN  NaN       38  \n",
       "1622          NaN              Yes     NaN  NaN       38  \n",
       "1794          NaN              Yes     NaN  NaN       38  \n",
       "1626          NaN              Yes     NaN  NaN       38  "
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sorted_phenotype = Immune.sort_values('Strains', ascending = False)\n",
    "sorted_phenotype.head(50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "PhenoID              object\n",
       "PhenoID.1             int64\n",
       "RecordID              int64\n",
       "Phenotype            object\n",
       "Shown_pheno          object\n",
       "Category             object\n",
       "Category_ID         float64\n",
       "color               float64\n",
       "Phenotype_post       object\n",
       "Phenotype_pre        object\n",
       "Authors              object\n",
       "Senior.Author        object\n",
       "Abbreviation         object\n",
       "Quantitive.trait     object\n",
       "Tissues              object\n",
       "Diet                 object\n",
       "Strains               int64\n",
       "dtype: object"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sorted_phenotype.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [],
   "source": [
    "phenotypes_interest =  sorted_phenotype[(sorted_phenotype['Shown_pheno'].str.contains('influenza') |\n",
    "                                         sorted_phenotype['Shown_pheno'].str.contains('Malaria')) &\n",
    "                                       (sorted_phenotype['Strains'] >= 50)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PhenoID</th>\n",
       "      <th>PhenoID.1</th>\n",
       "      <th>RecordID</th>\n",
       "      <th>Phenotype</th>\n",
       "      <th>Shown_pheno</th>\n",
       "      <th>Category</th>\n",
       "      <th>Category_ID</th>\n",
       "      <th>color</th>\n",
       "      <th>Phenotype_post</th>\n",
       "      <th>Phenotype_pre</th>\n",
       "      <th>Authors</th>\n",
       "      <th>Senior.Author</th>\n",
       "      <th>Abbreviation</th>\n",
       "      <th>Quantitive.trait</th>\n",
       "      <th>Tissues</th>\n",
       "      <th>Diet</th>\n",
       "      <th>Strains</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1600</th>\n",
       "      <td>X657</td>\n",
       "      <td>657</td>\n",
       "      <td>10865</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>H5N1 influenza A virus mortality rate 30 days ...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1601.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>Boon ACM, deBeauchamp J, Hollmann A, Luke J, K...</td>\n",
       "      <td>Webby</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1601</th>\n",
       "      <td>X893</td>\n",
       "      <td>893</td>\n",
       "      <td>10866</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>H5N1 influenza A virus survival time (10^4 EID...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1602.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>Infectious disease, immune system: H5N1 influe...</td>\n",
       "      <td>Boon ACM, deBeauchamp J, Hollmann A, Luke J, K...</td>\n",
       "      <td>Webby</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1782</th>\n",
       "      <td>X3655</td>\n",
       "      <td>3655</td>\n",
       "      <td>15133</td>\n",
       "      <td>Infectious disease, immune system: Malaria inf...</td>\n",
       "      <td>Malaria infection lethality, Plasmodium yoelii...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1783.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Malaria inf...</td>\n",
       "      <td>Infectious disease, immune system: Malaria inf...</td>\n",
       "      <td>Mogil RJ, Green D, Williams RW, Lu L, and coll...</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>63</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1851</th>\n",
       "      <td>X4233</td>\n",
       "      <td>4233</td>\n",
       "      <td>18440</td>\n",
       "      <td>Infectious disease, immune system: Malaria sus...</td>\n",
       "      <td>Malaria susceptibility, murine Plasmodium yoel...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1852.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune system: Malaria sus...</td>\n",
       "      <td>Infectious disease, immune system: Malaria inf...</td>\n",
       "      <td>Mogil RJ, Lu L, Green DR, Williams RW (contact...</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>60</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1682</th>\n",
       "      <td>X593</td>\n",
       "      <td>593</td>\n",
       "      <td>13009</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1683.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1681</th>\n",
       "      <td>X1868</td>\n",
       "      <td>1868</td>\n",
       "      <td>13008</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1682.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1685</th>\n",
       "      <td>X2558</td>\n",
       "      <td>2558</td>\n",
       "      <td>13012</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1686.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1683</th>\n",
       "      <td>X544</td>\n",
       "      <td>544</td>\n",
       "      <td>13010</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1684.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1684</th>\n",
       "      <td>X1481</td>\n",
       "      <td>1481</td>\n",
       "      <td>13011</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1685.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1679</th>\n",
       "      <td>X2637</td>\n",
       "      <td>2637</td>\n",
       "      <td>13006</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1680.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1680</th>\n",
       "      <td>X2468</td>\n",
       "      <td>2468</td>\n",
       "      <td>13007</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1681.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1676</th>\n",
       "      <td>X1071</td>\n",
       "      <td>1071</td>\n",
       "      <td>13003</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), per...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1677.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1678</th>\n",
       "      <td>X1832</td>\n",
       "      <td>1832</td>\n",
       "      <td>13005</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1679.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1677</th>\n",
       "      <td>X1618</td>\n",
       "      <td>1618</td>\n",
       "      <td>13004</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), per...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1678.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1687</th>\n",
       "      <td>X1586</td>\n",
       "      <td>1586</td>\n",
       "      <td>13014</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1688.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1675</th>\n",
       "      <td>X511</td>\n",
       "      <td>511</td>\n",
       "      <td>13002</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), per...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1676.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1674</th>\n",
       "      <td>X217</td>\n",
       "      <td>217</td>\n",
       "      <td>13001</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), per...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1675.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1673</th>\n",
       "      <td>X1797</td>\n",
       "      <td>1797</td>\n",
       "      <td>13000</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), per...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1674.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1672</th>\n",
       "      <td>X419</td>\n",
       "      <td>419</td>\n",
       "      <td>12996</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), mea...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1673.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1688</th>\n",
       "      <td>X2030</td>\n",
       "      <td>2030</td>\n",
       "      <td>13015</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1689.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1689</th>\n",
       "      <td>X1288</td>\n",
       "      <td>1288</td>\n",
       "      <td>13016</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1690.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1690</th>\n",
       "      <td>X1573</td>\n",
       "      <td>1573</td>\n",
       "      <td>13017</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1691.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1686</th>\n",
       "      <td>X2275</td>\n",
       "      <td>2275</td>\n",
       "      <td>13013</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1687.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: H1N1 (PR8...</td>\n",
       "      <td>Infectious disease, immune function: Schughart...</td>\n",
       "      <td>Schughart K</td>\n",
       "      <td>Schughart</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1666</th>\n",
       "      <td>X670</td>\n",
       "      <td>670</td>\n",
       "      <td>12969</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Malaria lethality, Plasmodium yoelii (PY17X su...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1667.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Mogil, RJ and Williams, R</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>54</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1665</th>\n",
       "      <td>X3733</td>\n",
       "      <td>3733</td>\n",
       "      <td>12968</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Malaria lethality, Plasmodium yoelii (PY17X su...</td>\n",
       "      <td>Immune</td>\n",
       "      <td>1666.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Infectious disease, immune function: Malaria l...</td>\n",
       "      <td>Mogil, RJ and Williams, R</td>\n",
       "      <td>Mogil</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>53</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     PhenoID  PhenoID.1  RecordID  \\\n",
       "1600    X657        657     10865   \n",
       "1601    X893        893     10866   \n",
       "1782   X3655       3655     15133   \n",
       "1851   X4233       4233     18440   \n",
       "1682    X593        593     13009   \n",
       "1681   X1868       1868     13008   \n",
       "1685   X2558       2558     13012   \n",
       "1683    X544        544     13010   \n",
       "1684   X1481       1481     13011   \n",
       "1679   X2637       2637     13006   \n",
       "1680   X2468       2468     13007   \n",
       "1676   X1071       1071     13003   \n",
       "1678   X1832       1832     13005   \n",
       "1677   X1618       1618     13004   \n",
       "1687   X1586       1586     13014   \n",
       "1675    X511        511     13002   \n",
       "1674    X217        217     13001   \n",
       "1673   X1797       1797     13000   \n",
       "1672    X419        419     12996   \n",
       "1688   X2030       2030     13015   \n",
       "1689   X1288       1288     13016   \n",
       "1690   X1573       1573     13017   \n",
       "1686   X2275       2275     13013   \n",
       "1666    X670        670     12969   \n",
       "1665   X3733       3733     12968   \n",
       "\n",
       "                                              Phenotype  \\\n",
       "1600  Infectious disease, immune system: H5N1 influe...   \n",
       "1601  Infectious disease, immune system: H5N1 influe...   \n",
       "1782  Infectious disease, immune system: Malaria inf...   \n",
       "1851  Infectious disease, immune system: Malaria sus...   \n",
       "1682  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1681  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1685  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1683  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1684  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1679  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1680  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1676  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1678  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1677  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1687  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1675  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1674  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1673  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1672  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1688  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1689  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1690  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1686  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1666  Infectious disease, immune function: Malaria l...   \n",
       "1665  Infectious disease, immune function: Malaria l...   \n",
       "\n",
       "                                            Shown_pheno Category  Category_ID  \\\n",
       "1600  H5N1 influenza A virus mortality rate 30 days ...   Immune       1601.0   \n",
       "1601  H5N1 influenza A virus survival time (10^4 EID...   Immune       1602.0   \n",
       "1782  Malaria infection lethality, Plasmodium yoelii...   Immune       1783.0   \n",
       "1851  Malaria susceptibility, murine Plasmodium yoel...   Immune       1852.0   \n",
       "1682  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1683.0   \n",
       "1681  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1682.0   \n",
       "1685  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1686.0   \n",
       "1683  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1684.0   \n",
       "1684  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1685.0   \n",
       "1679  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1680.0   \n",
       "1680  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1681.0   \n",
       "1676  H1N1 (PR8) influenza A virus (2x10E3 FFU), per...   Immune       1677.0   \n",
       "1678  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1679.0   \n",
       "1677  H1N1 (PR8) influenza A virus (2x10E3 FFU), per...   Immune       1678.0   \n",
       "1687  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1688.0   \n",
       "1675  H1N1 (PR8) influenza A virus (2x10E3 FFU), per...   Immune       1676.0   \n",
       "1674  H1N1 (PR8) influenza A virus (2x10E3 FFU), per...   Immune       1675.0   \n",
       "1673  H1N1 (PR8) influenza A virus (2x10E3 FFU), per...   Immune       1674.0   \n",
       "1672  H1N1 (PR8) influenza A virus (2x10E3 FFU), mea...   Immune       1673.0   \n",
       "1688  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1689.0   \n",
       "1689  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1690.0   \n",
       "1690  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1691.0   \n",
       "1686  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...   Immune       1687.0   \n",
       "1666  Malaria lethality, Plasmodium yoelii (PY17X su...   Immune       1667.0   \n",
       "1665  Malaria lethality, Plasmodium yoelii (PY17X su...   Immune       1666.0   \n",
       "\n",
       "      color                                     Phenotype_post  \\\n",
       "1600    5.0  Infectious disease, immune system: H5N1 influe...   \n",
       "1601    5.0  Infectious disease, immune system: H5N1 influe...   \n",
       "1782    5.0  Infectious disease, immune system: Malaria inf...   \n",
       "1851    5.0  Infectious disease, immune system: Malaria sus...   \n",
       "1682    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1681    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1685    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1683    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1684    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1679    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1680    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1676    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1678    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1677    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1687    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1675    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1674    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1673    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1672    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1688    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1689    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1690    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1686    5.0  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1666    5.0  Infectious disease, immune function: Malaria l...   \n",
       "1665    5.0  Infectious disease, immune function: Malaria l...   \n",
       "\n",
       "                                          Phenotype_pre  \\\n",
       "1600  Infectious disease, immune system: H5N1 influe...   \n",
       "1601  Infectious disease, immune system: H5N1 influe...   \n",
       "1782  Infectious disease, immune system: Malaria inf...   \n",
       "1851  Infectious disease, immune system: Malaria inf...   \n",
       "1682  Infectious disease, immune function: Schughart...   \n",
       "1681  Infectious disease, immune function: Schughart...   \n",
       "1685  Infectious disease, immune function: Schughart...   \n",
       "1683  Infectious disease, immune function: Schughart...   \n",
       "1684  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1679  Infectious disease, immune function: Schughart...   \n",
       "1680  Infectious disease, immune function: Schughart...   \n",
       "1676  Infectious disease, immune function: Schughart...   \n",
       "1678  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1677  Infectious disease, immune function: Schughart...   \n",
       "1687  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1675  Infectious disease, immune function: Schughart...   \n",
       "1674  Infectious disease, immune function: Schughart...   \n",
       "1673  Infectious disease, immune function: Schughart...   \n",
       "1672  Infectious disease, immune function: Schughart...   \n",
       "1688  Infectious disease, immune function: H1N1 (PR8...   \n",
       "1689  Infectious disease, immune function: Schughart...   \n",
       "1690  Infectious disease, immune function: Schughart...   \n",
       "1686  Infectious disease, immune function: Schughart...   \n",
       "1666  Infectious disease, immune function: Malaria l...   \n",
       "1665  Infectious disease, immune function: Malaria l...   \n",
       "\n",
       "                                                Authors Senior.Author  \\\n",
       "1600  Boon ACM, deBeauchamp J, Hollmann A, Luke J, K...         Webby   \n",
       "1601  Boon ACM, deBeauchamp J, Hollmann A, Luke J, K...         Webby   \n",
       "1782  Mogil RJ, Green D, Williams RW, Lu L, and coll...         Mogil   \n",
       "1851  Mogil RJ, Lu L, Green DR, Williams RW (contact...         Mogil   \n",
       "1682                                        Schughart K     Schughart   \n",
       "1681                                        Schughart K     Schughart   \n",
       "1685                                        Schughart K     Schughart   \n",
       "1683                                        Schughart K     Schughart   \n",
       "1684  Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...     Schughart   \n",
       "1679                                        Schughart K     Schughart   \n",
       "1680                                        Schughart K     Schughart   \n",
       "1676                                        Schughart K     Schughart   \n",
       "1678  Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...     Schughart   \n",
       "1677                                        Schughart K     Schughart   \n",
       "1687  Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...     Schughart   \n",
       "1675                                        Schughart K     Schughart   \n",
       "1674                                        Schughart K     Schughart   \n",
       "1673                                        Schughart K     Schughart   \n",
       "1672                                        Schughart K     Schughart   \n",
       "1688  Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu...     Schughart   \n",
       "1689                                        Schughart K     Schughart   \n",
       "1690                                        Schughart K     Schughart   \n",
       "1686                                        Schughart K     Schughart   \n",
       "1666                          Mogil, RJ and Williams, R         Mogil   \n",
       "1665                          Mogil, RJ and Williams, R         Mogil   \n",
       "\n",
       "     Abbreviation Quantitive.trait Tissues Diet  Strains  \n",
       "1600          NaN              Yes     NaN  NaN       69  \n",
       "1601          NaN              Yes     NaN  NaN       69  \n",
       "1782          NaN              Yes     NaN  NaN       63  \n",
       "1851          NaN              Yes     NaN  NaN       60  \n",
       "1682          NaN              Yes     NaN  NaN       56  \n",
       "1681          NaN              Yes     NaN  NaN       56  \n",
       "1685          NaN              Yes     NaN  NaN       56  \n",
       "1683          NaN              Yes     NaN  NaN       56  \n",
       "1684          NaN              Yes     NaN  NaN       56  \n",
       "1679          NaN              Yes     NaN  NaN       56  \n",
       "1680          NaN              Yes     NaN  NaN       56  \n",
       "1676          NaN              Yes     NaN  NaN       56  \n",
       "1678          NaN              Yes     NaN  NaN       56  \n",
       "1677          NaN              Yes     NaN  NaN       56  \n",
       "1687          NaN              Yes     NaN  NaN       56  \n",
       "1675          NaN              Yes     NaN  NaN       56  \n",
       "1674          NaN              Yes     NaN  NaN       56  \n",
       "1673          NaN              Yes     NaN  NaN       56  \n",
       "1672          NaN              Yes     NaN  NaN       56  \n",
       "1688          NaN              Yes     NaN  NaN       56  \n",
       "1689          NaN              Yes     NaN  NaN       56  \n",
       "1690          NaN              Yes     NaN  NaN       56  \n",
       "1686          NaN              Yes     NaN  NaN       56  \n",
       "1666          NaN              Yes     NaN  NaN       54  \n",
       "1665          NaN              Yes     NaN  NaN       53  "
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "phenotypes_interest.head(50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(25, 17)"
      ]
     },
     "execution_count": 73,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "phenotypes_interest.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "metadata": {},
   "outputs": [],
   "source": [
    "phenotypes_dataframe = phenotypes_interest[['PhenoID', 'Shown_pheno']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PhenoID</th>\n",
       "      <th>Shown_pheno</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1600</th>\n",
       "      <td>X657</td>\n",
       "      <td>H5N1 influenza A virus mortality rate 30 days ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1601</th>\n",
       "      <td>X893</td>\n",
       "      <td>H5N1 influenza A virus survival time (10^4 EID...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1782</th>\n",
       "      <td>X3655</td>\n",
       "      <td>Malaria infection lethality, Plasmodium yoelii...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1851</th>\n",
       "      <td>X4233</td>\n",
       "      <td>Malaria susceptibility, murine Plasmodium yoel...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1682</th>\n",
       "      <td>X593</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     PhenoID                                        Shown_pheno\n",
       "1600    X657  H5N1 influenza A virus mortality rate 30 days ...\n",
       "1601    X893  H5N1 influenza A virus survival time (10^4 EID...\n",
       "1782   X3655  Malaria infection lethality, Plasmodium yoelii...\n",
       "1851   X4233  Malaria susceptibility, murine Plasmodium yoel...\n",
       "1682    X593  H1N1 (PR8) influenza A virus (2x10E3 FFU), med..."
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "phenotypes_dataframe.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "metadata": {},
   "outputs": [],
   "source": [
    "def to_disease(string):\n",
    "    if 'Malaria' in string:\n",
    "        return 'Malaria'\n",
    "    else:\n",
    "        return 'Influenza'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/mjouve/opt/anaconda3/envs/ntds/lib/python3.7/site-packages/ipykernel_launcher.py:1: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: http://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  \"\"\"Entry point for launching an IPython kernel.\n"
     ]
    }
   ],
   "source": [
    "phenotypes_dataframe['Disease'] = phenotypes_dataframe['Shown_pheno'].copy().apply(lambda string: to_disease(string))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PhenoID</th>\n",
       "      <th>Shown_pheno</th>\n",
       "      <th>Disease</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1600</th>\n",
       "      <td>X657</td>\n",
       "      <td>H5N1 influenza A virus mortality rate 30 days ...</td>\n",
       "      <td>Influenza</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1601</th>\n",
       "      <td>X893</td>\n",
       "      <td>H5N1 influenza A virus survival time (10^4 EID...</td>\n",
       "      <td>Influenza</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1782</th>\n",
       "      <td>X3655</td>\n",
       "      <td>Malaria infection lethality, Plasmodium yoelii...</td>\n",
       "      <td>Malaria</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1851</th>\n",
       "      <td>X4233</td>\n",
       "      <td>Malaria susceptibility, murine Plasmodium yoel...</td>\n",
       "      <td>Malaria</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1682</th>\n",
       "      <td>X593</td>\n",
       "      <td>H1N1 (PR8) influenza A virus (2x10E3 FFU), med...</td>\n",
       "      <td>Influenza</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     PhenoID                                        Shown_pheno    Disease\n",
       "1600    X657  H5N1 influenza A virus mortality rate 30 days ...  Influenza\n",
       "1601    X893  H5N1 influenza A virus survival time (10^4 EID...  Influenza\n",
       "1782   X3655  Malaria infection lethality, Plasmodium yoelii...    Malaria\n",
       "1851   X4233  Malaria susceptibility, murine Plasmodium yoel...    Malaria\n",
       "1682    X593  H1N1 (PR8) influenza A virus (2x10E3 FFU), med...  Influenza"
      ]
     },
     "execution_count": 78,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "phenotypes_dataframe.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [],
   "source": [
    "phenotypes_dataframe.set_index('PhenoID', inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
